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2.2 Coronary bypass graft surgery.
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SUMMARY
An analysis has been conducted of the outcome following
cardiac valve surgery and coronary artery bypass grafting performed
in the Royal Adelaide Hospital Cardiothoracic Surgical Unit over a 25
year period.
Pre-operative and post-operative data was collected on all
patients undergoing surgery and a follow-up questionnaire sent to
various patient groups to assess survival, symptomatic outcome,
complications and current employment. In excess of 7000 individual
patients were contacted with 98Vo complete follow-up being achieved.
With acurate survival data, potential risk factors were analyzed and
inter and intra group comparisons made.
Isolated aortic valve replacement occurred in 601 patients with
657o having a Starr-Edwards valve and 33Vo a Bjork-Shiley. Hospital
mortality over the period of review fell from 8.6Vo in the first decade,
to 2.9vo in the second decade. Poor long term survival was
significantly influenced by poor ventricular function, dyspnoea,
cardiac pathology and atrial fibrillation. Haemorrhagic and embolic
complications requiring hospitalization occurred at a constant rate. No
evidence of significant valve superiority was found in the aortic
position or mitral position. In a subsequent group the use of the
aortic Bjork-Shiley Monostrut Valve in 315 patients showed
comparable results to the preceding model without the complication
of strut fracture.
Mitral valve replacement occurred in 534 patients with 94Vo of
patients having a. Starr-Edwards valve inserted. The mean hospital
mortality fell from 4.8Vo in the first decade of surgery, to 3.67o in the
second. Pre-operative predictors of long term survival found in the
X
aortic group pertained to the mitral patient as did the incidence of
complications. Dyspnoea was significantly improved in both aortic
and mitral valve patients at time of review.
The first 4001 patients to undergo coronary artery bypass
grafting $rere also reviewed. Five year survival was glVo with an
overall hospital mortality of 27o. Angina, dyspnoea and activity \Arere
all significantly improved post-operatively. A small "drop off" (47o)
from the workforce occurred following surgery. The cost of the
surgery in 1982 prices being $3,476.00 per patient. When patients
who had undergone coronary artery bypass grafting at least l0 years
earlier were reviewed, 167o had required re-operation, however the
only predictor of a re-operation found was inadequate initial surgery.
Diabetic patients undergoing coronary artery bypass grafting
had a significantly poorer short and long term survival than non
diabetic patients. In particular, there was significantly poorer
survival for diet controlled diabetic patients and this group may
warrant closer post-operative surveillance.
When coronary artery bypass grafting was combined with
another cardiac procedure such as valve replacement or aneurysm
plication, although the addition of the coronary artery bypass grafting
carried no additional risks, it did not appear to enhance survival.
A review of the first 1155 coronary artery angioplasties and the
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FOR PATIENTS UNDERGOING MECHANICAL VALVE
REPLACEMENT SURGERY
Answers to the following questions are sought:
What trends in patient, selection and operative details have
occurred in twenty five years of valve replacement surgery in
both the mitral, aortic and multiple valve replacements?
Have different prosthetic models altered the survival or
complications for these patients?
What risk factors affecting longterm survival can be identified in
these patients pre-operatively?
What is the symptomatic outcome following surgery?
How does the Bjork-Shiley Monostrut Aortic Valve perform in the
short term?
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1.2 FOR PATIENTS WHO T'NDERGO CORONARY ARTERY
BYPASS GRAFT SURGERY
Answers to the following questions are sought:
(i) What trends in patient selection and operative detail has
occurred in the first decade of coronary ar¡ery bypass surgery?
(ii) What is the hospital and longterm mortality for these patienrs?
What risk factors can be identified?
(iii) What is the symptomatic outcome for these patients?
(iv) Is return to work and activity affected by the surgery?
(v) Is the surgery cost effective?
(vi) tilhy do patients present for redo surgery and can they be
predicted at time of initial surgery?
(vii) Is the outcome for redo patients different than those presenting
for initial surgery?
(viii)What is the likelihood of redo operation 10 years afrer initial
coronary artery bypass graft surgery?
(ix) What effect does diabetes have on patients undergoing coronary
artery bypass graft surgery? Does the outcome depend on the
insulin dependent status of the patients?
(x) Does the addition of coronary artery bypass graft surgery to
other cardiac surgery, alter the prognosis for these patients?
(xi) What is the risk of emergency surgery following coronary artery
angioplasty?
(xii) How many patients undergoing coronary artery angioplasty
require subsequent coronary artery surgery and when does this
occur?
(xiii) How does angioplasty's ability to relieve symptoms compare




From antiquity until comparatively recent times, the heart has
been considered outside the limits of surgery. As late as 1886, the
usually perceptive historian Stephen paget wrote:
"Surgery of the Heart has probably reached the limits set by nature to
all surgery, no new method and no new discovery can overcome the
natural difficulties that attend a, wound of the heart" (Lyons, 1978).
Ironically, it was in that same year that Ludwig Rehn successfully
repaired r laceration of the heart and a. new era, of cardiac surgery
had begun (Rehn, 1913).
The advancement of cardiothoracic surgery has relied heavily
on technical developments. It was Werner Forssmann who, while an
Intern in a German hospital, first demonstrated cardiac
catheterization, trying to devise a technique for emergency injection
of drugs directly into the heart. He did this in lg2g, while standing
behind a fluoroscopic screen and looking into a mirror which enabled
him to visualize a thin catheter which he threaded through an arm
vein and successive venous channels into his heart (Forssman, lg2g).
It was not however until Cournard, a French Graduate working in New
York, established cardiac catheterization in 1941, that this valuable
technique opened the way for further advances in cardiac physiology
and surgery. These two pioneers shared the Nobel Pnze for Medicine
in 1956 (Morris and schirmer, 1990). In lgs3, seldinger of
Stockholm popularized transarterial catheterization (Seldinger, 1953),
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which lvas extended finally to successful coronary cine-angiography
by Sones in Cleveland, in 1962. This was occurring concunently with
the construction by Gibbon of the Heart-Lung Machine (Gibbon, 1954),
which led to Effler and his colleagues in Cleveland developing a vein
by-pass technique for myocardial ischaemia (Favaloro et &1, l97O).
2.1 CARDIAC VALVES
The first implanted artificial valve in the human circulatory
system was performed by Hufnagel, in 1953 and heralded the
beginning of a variety of prosthetic devices available for use in
cardiovascular surgery. Improvements in design and construction
were followed with many modifications often failing to demonstrate
longterm advantages and indeed some have proven positively
harmful.
CLASSIFICATION
Four functional categories of prosthetic valves exist: caged ball,
caged disc, tilting disc and tissue valve. The original Hufnagel
prosthesis was of the caged ball variety and was implanted in the
descending aorta in patients with severe aortic insufficiency (Hufnagel
et al, 1954). Harkin performed the first sub-coronary implantation of
a caged ball valve in a group of patients with aortic regurgitation in
1960, but was unable to achieve survival for longer than three
months, in 9 of I I patients in his series (Harken et â1, 1960; 1962).
The first insertion of a. caged ball valve in the mitral position was
performed by starr also in 1960 (Starr and Edwards, 1961). The
caged disc valve \ilas introduced between 1964 and 1965, by r
number of investigators (Hufnagel and Conrad, 1965; Kay et â1, 1966
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a, b; Cross and Jones, 1966). Similar in design, but all attempting to
offer the advantages of a lower profile, improved haemodynamics and
lighter weight, than the caged ball valve. Beall in 1967, (Beall et al,
1968) further modified the design to diminish the valve's thrombotic
potential. The tilting disc prosthesis \ilas introduced in 1967 by
Wadda, Bjork and Lillehei (Wadda et al, 19721' Bjork, 1969; Lillehei et
â1, 1974) providing a greater approximation of laminar flow than did
the caged valves. The tissue valve made its first appearance in 1962,
in the form of a fresh aortic valve homograft, used successfully for
aortic valve replacements by Ross, Duran and Barratt-Boyes (Ross,
1962; Duran and Gunning, 1962; Barratt-Boyes, 1964), after previous
trials in the descending aorta (Murray, 1956; Kerwin, 1962). Initial
favourable results were tempered by reports of early degeneration,
rendering the bioprosthesis a less attractive alternative at the time
(Ross, 1972; Angel et al, 1972; Wallace, 1975; Moore et al, 1975).
The clinical introduction of the aortic heterograft in 1967
(Ionescu et ô1, 1967; Carpentier et rl, 1968) and the subsequent
development of a glutaraldehyde tanning technique that substantially
increased the valve's durability, stimulated renewed interest in these
valves (Carpentier et ä1, 1969). Glutaraldehyde preservation
techniques were subsequently applied to valves constructed of fascia
lata (Ionescu and Ross, 1969) and bovine pericardium with
satisfactory results (Ionescu et al, 1972).
First introduced by Gott in 1968, the bileaf tilting disc valve was
designed to provide entirely central flow. The most recent bileave
prosthesis was devised by St. Jude Medical Incorporated and has been
studied in clinical trials since 1977 (Nicoloff and Emery, 1979; Duncan
et al, 1983; Horstkotte et al, 1983; Aurelio et al, 1984; Douglas et al
l e85).
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In a careful review of prosthetic heart valves (McClung et al,






v ) Ease of implantation,
vi) Patient acceptability,
vii) Low incidence and diminished severity of late prosthetic
endocarditis and
viii) Anatomic suitability of the valve to its implanted location.
There is presently little difference between any of the four types of
prostheses in terms of ease of surgical implantation. In addition, none
of the valves norry in use are sufficiently noisy as to be unduly
disturbing to the patient. The remaining six characteristics serve as a
framework through which the various types of substitute separate
valves may be evaluated.
STARR-EDWARDS CAGED BALL VALVE
The valve models that have been used in over 957o of patients in
the Cardiothoracic Surgical Unit at the Royal Adelaide Hospital, are the
Starr-Edwards caged ball valve and Bjork-Shiley tilting disc valve.
The Starr-Edwards valve prosthesis is the most widely known and
extensively studied caged ball valve. The original models 6000 mitral
and 1000 aortic, \ilere constructed of a heat cured silicon rubber ball
housed in a caged structure made from Stellite 2l (an alloy of cobalt
chromiummolybdenum and nickel) and anchored by a sewing ring of
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teflon cloth (Starr and Edwards, 196l). While the valve provided
adequate haemodynamics in both the aortic and mitral positions,
haemolysis was a significant problem in the former. Anticoagulation
was mandatory. The 1260 prosthesis was developed in 1965 and has
continued to enjoy popularity. In this valve r teflon cloth covering
was extended over the entire seat as a means of providing
endothelialization about the orifice. This resulted in a significant
reduction in the rate of thromboembolism from 34Vo in the model
1000, to l97o in the model 1260 (Starr, 1972). Ball variance in the
model 1000 and 6000 resulted in both obstructive phenomena and
the fatal poppet embolization. This problem was dealt with in models
1260 and 6120 by a minimal reduction in temperature of the curing
process, as well as the addition of an extra lÙVo silicon dioxide or
fluorosilicone filler. Additional alterations included an increase in the
orifice to ball diameter ratio (88Vo), modification of the orifice
configuration to reduce opening pressure and a decrease in the overall
weight of the prosthesis by reduction in its metallic composition (Herr
et al, 1968).
Series 2300 aortic and 6300 mitral prostheses eliminated ball
variance by replacing the silicon rubber poppet with a hollow Stellite
2l sphere (Starr et â1, L967). Based on observations (Braunwald and
Bonchek, 1967) that neo-intimal proliferation along cloth covered
valve struts substantially reduced the threat of thrombus formation,
these valves employ completely cloth covered struts. They were
subsequently modified to include a. "composite seat" that featured a
ring of small metallic studs projecting through the teflon cloth of the
valve orifice, that both increased the orifice to ball diameter ratio and
reduced wear on the orifice cloth. In clinical trials thromboembolic
phenomena \rere initially noted to be substantially reduced in both
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the aortic and mitral positions, however continuous anticoagulation
remained mandatory (Hodam et al, l97l: Bonchek and Stan, 1975).
Reports of cloth wear and pronounced haemolysis with the cloth
covered valve particularly in the aortic position (Roberts et al, 1973),
encouraged development of the series 2400 and 6400 composite strut
"track valve" in 1972. The valve was virtually identical in
construction to the composite seat cloth covered series, but
incorporated strips of Stellite 2l on the inner surface of each strut,
providing a, metallic track that protected the teflon covering from
trauma resulting from ball impact. Early studies on this model
revealed substantial thrombogenesis in the absence of anticoagulation
(Stein et al, 1976). Later reports suggested that there was no greater
thromboembolic potential associated with the valve than with other
valve prosthesis, if the patients were appropriately anticoagulated
(Starr et ô1, 1977a). Haemolysis remained significant resulting in the
abandonment of the cloth covered struts, entirely in favour of the
earlier non cloth covered model 1260 aortic and model 6120 mitral
valves.
RESULTS WITH TT{E STARR-EDWARDS VALVE
Aortic Replacement
Initially hospital mortality for aortic valve replacement with all
the presently available prostheses, was reported to be between SVo
and \Vo in multiple series (Anderson et al, 1973; Thompson et â1,
1979; Foreman et â1, 1980; Bonchek, 1981). Subsequent data using
cold cardiaplegia for myocardial preservation, revealed hospital
mortality lower than l%o for isolated aortic valve replacement (Jacobs
et al, 1980). Mortality is not a function of the type of valve used, but
rather a. combination of well known peri-operative complications such
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as peri-operative myocardial infarction, left ventricular failure and
ventricular dysrhythmia. Late mortality ranges from l57o - 2OVo at 5
years (Bonchek, l98l) and also appears independent of the type of
prosthesis employed. Haemodynamics are generally similar in all
models with average gradient varying from 10 - 19 mmHg in multiple
trials (McHenry et al, 1967).
Thromboembolic conditions in anticoagulated patients also tend
to be relatively similar, with l.5Vo - ZVo patients a year reported for
Starr 24OO model (Starr et al, 1977b) and 57o over 4 years noted for
the Smelloff-Cutter valve (Bloodwell et â1, 1969). Bonchek and Starr
in 1975 observed no thromboembolic events in 116 anticoagulated
patients followed for three years with cloth covered (2310 - 2320)
valves. In contrast they found 8.8Vo incidence over two years in
patients who were not anticoagulated and 29.47o incidence in patients
followed for two years who had discontinued previous
anticoagulation. Haemolysis is noted in all types of mechanical
prostheses, however, frank haemolytic anaemia has been associated
with cloth covered aortic devices and in the presence of peri-valvular
leaks (Santinga and Kirsh, 1972).
Mitral Replacement
Operative mortality for elective mitral valve replacement in
New York Heart Association Class 3 patients is between l7o and 3Vo
(Bonchek, l98l), although the figures become somewhat higher if
Class 4 patients aÍe included. Late mortality is virtually identical to
that reported for aortic valve replacement (Bonchek and Starr, 1975),
with only lÙVo - L5Vo of these related to complications of the
prosthesis itself. Mean resting valve gradients have ranged from 5
9 mmHg although they have been observed to increase as much as
three fold during exercise (Starr et â1, 1977b). Thromboembolic
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events are reported more commonly in mitral position than in the
aortic, although haemolysis is less pronounced. The Starr-Edwards
model 6400 composite strut valve was associated with a 37o per
patient year rate of thromboembolism (Starr et ô1, 1976).
COMPLICATIONS
Flow Obstruction
Flow obstruction is an intrinsic feature of the caged ball valve
by virtue of its design. Three sites of obstructive flow are
immediately apparent:
i) the valve orifice itself,
ii) the outflow orifice defined by the oblique distance between the
respective circumferences of the valve seat and the ball in the
open position and
iii) the centrally obstructed channel defined by the distance
between the circumference of the ball and the surrounding
tissue. Centrally obstructive flow causes a substantial amount of
turbulence, particularly in the aortic position where flow
velocity is at least three times that across the mitral valve.
Thrombosenicitv
While necropsy studies have demonstrated the presence of
prosthetic thrombi, in the vast majority of patients with caged ball
valves, only a minority of these have displayed clinical evidence of
embolic events antemortem (Roberts et â1, 1973). Location of the
thrombus is variable and is in part dependent upon the type of valve
employed. There is predilection for thrombus formation at the
junction of the struts with the seat in non cloth covered valves, while
it is more commonly found at the apex of the cage in non close
clearance cloth covered models. Thrombus formation in a small group
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of close clearance cloth covered aortic prosthesos appeared primarily
at the mid portion of the struts and was reported to be responsible for
reduced forward exertion of the ball with consequent mortality.
A re-evaluation of actuarial thrombotic rates by McManus et al
(1980), reveals that thromboemboli were significantly more common
from aortic and mitral silicon ball valves during the first decade of
cardiac valve replacement than they have been for the second, using
identical valve models. This difference probably reflects diminished
ball variance as a result of alterations in silicon curing techniques.
Thromboembotic rates in the anticoagulated patient with the Starr-
Edwards silicon ball valve appears equivalent to those as observed in
patients with both tilting disc and tissue valve prostheses.
Some evidence has been presented suggesting that the use of
acetylsalicylic acid in combination with anticoagulant therapy is more
effective than anticoagulants alone, in the prevention of thrombotic
episodes (Dale et al, 1977). Not withstanding the use of antiplatelet
agents, in the absence of anticoagulation, it has been shown
unequivocally to be not only inferior to anticoagulant therapy alone,
but little better than no medication whatsoever for thromboembolism




Silicon ball variance was a persistent problem in prosthetic
devices implanted prior to alteration to the curing technique in 1965,
especially those mounted in the aortic position. Swelling of the ball
was observed with frequent reports of impaction in the cage. Trauma
inflicted by the valve struts upon a swollen lipid laiden poppet has
been implicated in the pathogenesis of ball distortion, fracture, and
embolization, all of which probably represent a spectrum of the same
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phenomenon. The low reported incidence of ball variance in the
mitral position appears to be related to a combination of factors. Not
only is the mitral prothesis subject to diastolic pressures that are
substantially lower than those in the aortic position, but the impact of
the ball when subjected to the higher velocity of ventricular systole is
directed towards the valve seat rather than the apex of the cage
rendering it less likely to the grooving and distortion observed in
aortic devices. Cloth strut wear in model 2310 and 2320 Starr-
Edwards Aortic prostheses has been associated both with an increased
incidence of haemolysis and a decreased longevity of the valve itself.
Haemolvsis
Haemolysis is a complication of all mechanical cardiac valves,
although it rarely leads to frank anaemia, unless the prosthesis is
cloth covered and located in the aortic position or a peri-valvular leak
is present. The increased turbulence associated with both intact and
damaged cloth covered struts provides an environment particularly
conductive to intravascular traumatic haemolysis. Post mortem
examinations performed by Roberts et al (1973), have revealed not
only a. high incidence of renal haemosiderosis in patients with aortic
valve replacement, but also a significantly greater severity of iron
deposition than that found in patients with mitral replacement alone.
Endocarditis
The majority of clinical investigations of prosthetic endocarditis
have been performed in patient populations with Starr-Edwards cage
ball valves. There has been no evidence of any significantly greater
predilection to infection in one model over another. Incidence is
variably reported in the range between lVo and 4Vo (Slaughter et â1,
1973), between 36c/o and 53% of these cases are documented within
two months of surgical implantation and aÍe designated as early
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prosthetic valve endocarditis. The most common ethological
organisms are Staphylococcus aureus and epidermidis, accounting for
more than half the infections with the remainder due to
Streptococcus, fungal species and gram negative organisms. Common
sources include wound infections, urinary tract infections, intravenous
infusion equipment and cardiopulmonary bypass pumps. The
infection commonly involves the suture line and is highly virulent
with reported morølity rate as high as 8'17o, regardless of the mode of
therapy employed (Dismukes et â1, 1973).
Late prosthetic valve endocarditis is a. different patho-
physiological entity, both aetiologically and prognostically. The
pathogenic strain is noted to be Streptococcus species in 42Vo, a
Staphylococcal organism in 257o, a gram negative in l6Vo and a
Diptheriod in lOVo (Karchmer et ô1, 1978). Only one case of late
prosthetic candidiasis was documented secondary to an infected llio-
condute. Sources of infection in the remaining cases were those
commonly associated with endocarditis in the general population, e.g.
dental manipulation, peri-odontitis, genito-urinary manipulation.
Mortality rate has been reported to range from 35 - 53Vo (Karchmer et
al, 1978). Streptococcal infections fare the best with the late survival
rate of 617o in Karchmer's population, in comparison with 36Vo in the
non Sfreptococcal group. In all series a significant number of cases
were potentially preventable by antibiotic prophylaxis.
Roberts et 71, (1973) have described inflammatory processes
extending through the atrial septum into the atrioventricular junction,
as well as deep into . other contiguous structures in five patients
studied at post mortem examination with late aortic prosthetic valve
endoca¡ditis. All five cases \ilere observed to manifest massive aortic
insufficiency secondary to partial, or complete detachment of the
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valve from the aortic route. In a larger series of 22 patients,
prosthetic valve ring abscesses !\rere documented in all cases
regardless of the site of the valve involved (Arnett and Roberts,
1976). Involvement of the entire circumference of the prosthesis
leading to valve detachment was observed in 8O7o of patients with
aortic prosthetic endocarditis and in 28% of patients with prosthetic
mitral lesions. While prosthetic mitral valve endocarditis is
commonly accompanied by valve dehiscence and regurgitation, mitral
prosthetic infection is more frequently associated with valve
obstruction caused by vegetative material (Watanakunakorn, 1979).
Karchmer et al (1978) has confirmed the importance of prosthetic
regurgitant lesions, clinically demonstrating a, two-fold increase in
mortality in patients developing insufficiency murmurs.
Atrioventricular conduction abnormalities were universally associated
with a fatal outcome. Increasing duration of a febrile course was also
know to correlate with more extensive myocardial invasion at
autopsy. Candida and Aspergillus species are responsible for nearly
all reported cases of fungal prosthetic endocarditis. Mortality remains
greatü than 90Vo regardless of the therapeutic modality employed
(Harford, 1974).
Anatomic Suitability
The prime anatomic disadvantage of the caged ball valve is its
size. The spacial requirements for the prosthesis have been
responsible for an extraordinary variety of post-operative
complications more commonly seen in the mitral, than in the aortic
position. The absence of ventricular dilatation in the patient with
pure mitral stenosis has both haemodynamic and electro-physiological
consequences following mitral valve replacements. Incomplete
forward motion of a, poppet has been reported as a result of
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ventricular myocardium interposed between the struts of the cage, a
phenomenon that has greatly enhanced biconcentric hypertrophy in
the presence of co-existent aortic stenosis (Roberts et â1, 1973). In
the presence of a small ventricular chamber obstruction to ventricular
emptying can occur with the Starr-Edwards valve in the closed
position, because of its intrusion into the ventricular outflow tract.
Erosion of the ventricular septum in the vicinity of the conduction
system as well as trauma to the ventricular free wall, have been
responsible for fatal dysrhythmia (Robicsek et al, 1967). Use of the
valve in the tricuspid position has resulted in stenotic obstructive and
thrombotic complications similar to, if not more frequent than those
encountered in the mitral replacement (VanderVeer et â1, l97l).
BJORK-SHILEY TILTING DISC VALVE
Evolution
The concept of a tilting disc prosthesis was introduced by Wada
in 1968, when he designed a valve that allowed a teflon disc in a
titanium housing to pivett open to an angle of 750-800 providing semi
centralized flow. Although haemodynamically successful, the valve
developed problems with early degeneration of the hinged teflon disc
leading to its withdrawal from production. Complications included
regurgitant flow through the prosthesis itself and severe disc
variation with at least 13 reported cases of disc disengagement and
embolization from both aortic and mitral positions (Bjork, l97O; Roe et
al, 1975).
In 1969, Bjork reported. preliminary studies on a new valve
consisting of a free floating Dell ringed disc suspended between two
cccentrically positioned struts in a, Stellitc housing dcsigncd to tilt
open to a maximum angle of 600. Incorporated into its design was the
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facility of the disc to rotate on its axis, in a fashion similar to that of a
phonograph record on a turntable, once every 180-200 cycles,
thereby substantially diminishing the wear caused by the hinge
struts. The Dell ringed disc proved to be relatively resistant to
thrombosis, as well as durable. However, a propensity to absorb
moisture during steam autoclaving \ryas found to lead to swelling of
the occluder, if it was not rigorously dried following sterilization. This
potential problem was solved with the advent of a pyrolytic carbon
disc in 1972 (McClung et al, 1983). Subsequently, a series of valves
were devised utilizing a convex-concave pyrolytic carbon disc, that
rises out of the housing somewhat when the valve is open, directing
more flow through the lesser orifice. The design is intended to
diminish the thrombogenecity and resistance to flow perhaps at the
expense of a moderate increase in regurgitation.
Results
Operative and late mortality for the tilting disc valve is similar
to that reported for other prosthetic implants (Lepley et â1, 1977).
Exercise gradients with the eccentric monocusp valves are not well
documented, however Bjork has reported doubling of aortic resting
gradient and tripling of mitral resting gradient on exercise (Bjork et
rl, 1973). Subsequent reporting of strut fracture (Lindblom er â1,
1986) lead to the development of monstrut valve, made from a single
cast with no welds included (Bjork, 1985). This did not, however,




Flow dynamics for the tilting disc prosthesis are better than for
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the Starr-Edwards prosthesis. Incomplete opening of the mitral
eccentric monocusp prosthesis can occur in the face of massive aortic
insufficiency however, this problem is quite lare unless encouraged
by incorrect positioning of the valve.
Valve Incompetence
Studies of the original Bjork mitral prosthesis demonstrated
regurgitant flow of up to l2%o-líVo in some patients, a, phenomenon
which was presumed to provide an antithrombotic "washing"
mechanism by the manufacturer (Bjork and Olin, 1970). Regurgitant
flow was eliminated by the introduction of the pyrolytic carbon disc,
that fit the valve orifice more snuggly than did its predecessor.
Thrombosenicitv
The thrombotic potential of the Bjork valve in the absence of
anticoagulation is well known. A substantial risk of thrombotic and
thromboembolic events remains in the patient who is not
anticoagulated. There aÍe multiple reports of thrombosis of the
prosthesis itself in both the aortic and mitral position, usually in
patients not receiving anticoagulation therapy. Necropsy studies
performed by Roberts and Hammer (1976) demonstrated no
obstructive prosthetic thrombosis in any patients treated with
Warfarin sodium, unless there was co-existing prosthetic endocarditis.
Similarly the overall incidence of prosthetic thrombosis associated
with the Bjork valve was less than that observed in anticoagulated
patients with caged ball valves. Thromboembolic events have been
reported to average l.9Vo per patient year with the Bjork-Shiley
prosthesis (Lepley et ô1, 1977).
Haemolvsis
Haemolysis in all tilting disc valves has been rcmarkably
minimal with few reports of haemolytic anaemia. Post mortem
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examination has reported the presence of renal haemosiderosis in 3 of
9 patients, however only one of these was noted to be severely
affected (Roberts and Hammer, 1976).
Endocarditis
Endocarditis has been no more frequently observed in tilting
disc prosthesis than in any other valve replacement, although it has
been associated with increased incidence of prosthetic thrombosis
(Lepley et al, 1977).
Anatomic Suitability
Reports of anatomic disproportion of tilting disc valves are rare.
Roberts and Hammer (1976) observed two cases in which the size of
the Bjork-Shiley prosthesis chosen for mitral valve replacement, was
too large for the left ventricular cavity, leading to incomplete opening
of the valve with result in prosthetic stenosis.
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2.2 CORONARY ARTERY BYPASS GRAFT SURGERY
Coronary artery bypass grafting (CABG) for ischaemic heart
disease was developed in the 1960's and has undergone refinement
since. Its true role in the treatment of ischaemic heart disease has
been the subject of considerable controversy (Silverman and
Grossman, 1984; Spodick, 1982), despite numerous studies. Both
medical and surgical treatment for myocardial ischaemic disease has
progressed rapidly (CASS, 1983a). Medical advances include calcium
channel blockers, thrombolysis and coronary angioplasty. Surgical
advances include increasing technical skills resulting from experience,
better peri-operative cîre and improved myocardial protection, which
has resulted in a decrease in peri-operative injury and mortality
(Kennedy et â1, 1980; Miller et â1, 1983b). The rates for operative
mortality and peri-operative myocardial injury for isolated CABG aÍe
l%o-2Vo and 27o-57o respectively (Hall et â1, 1983; Jones et ã1, 1980;
Kouchoukos et â1, 1980; McCormick et â1, 1983; Najafi, 1983;
Rahimtoola et al, 1981).
Coronary Artery Anatomy
In order to appreciate the rationale for CABG, a brief review is
presented of coronary anatomy and physiology. Arising from the
aorta just above the aortic valve ring, rÍe the right and left coronary
arteries, the initial portion of the left coronary artery is the left main
coronary artery and it rapidly divides into the left anterior
descending (LAD) branch and a circumflex branch. The LAD supplies
more of the myocardium than any of the other coronary arteries, its
area of distribution being the anterior wall of the left ventricle and
the majority of the intraventricular septum. The circumflex coronary
artery branches that supply the posterior wall of the tefq ventricle
and the terminal portions may supply the inferior portion of the heart
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also. The right coronary artery (RCA) primarily supplies the right
ventricle, but its terminal porìion ends in the posterior descending
artery (PDA), which supplies the inferior surface of the left ventricle,
as well as part of the interventricular soptum. The RCA may continue
to give other branches to the posterior wall of the left ventricle. The
PDA may arise from either the right coronary artery or the circumflex
coronary artery or there may be branches from both. The LAD, the
circumflex and the RCA, compose the three major arterial systems
that supply the left ventricle, these are the systems involved when
references are made to single, double and triple vessel coronary
artery disease. The LAD, the circumflex and to a. lesser extent the
PDA all give off branches that may be individually involved with
atherosclerosis.
Although colateral channels between the coronary arteries are
not prominent in the normal states, they do develop and become quite
important when there are significant stenoses in any of the arteries.
For example, a normal LAD can form colateral vessels that supply
areas of the heart, that are normally supplied by an obstructed PDA
and vice versa. The flow through the coronary arteries varies
depending on the myocardial requirements, however the ability to
increase flow is impaired by atherosclerosis. There is a large
capability for reserve flow. In fact, only when 707o of the cross
sectional atea of a coronary artery is obstructed, does flow decrease
significantly. This is equal to a 507o reduction in diameter as
measured on angiography. As flow becomes impaired the clinical
manifestations of ischaemic heart. disease progress, from angina to
infarction (Christian et al, 1985).
Progression of Atherosclerosis and Risk Factors.
Ischaemic heart disease caused by atherosclerosis is a, complex
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progressive disease (Haft and Bachik, 1984; Kramer et â1, 1983)
resulting from inherited and enviromental factors. The rate of
progression of stenoses in an individual patient cannot be predicted
easily (Shub et al, l98l) and occlusion due to thrombus formation at a
stenosis, or due to spasm, is the usual cause of acute infarction. It
occurs often without warning. Inherited factors play an important
role in the development of atherosclerosis, but the variable expression
of these factors complicates our ability to make predictions about the
disease and little control can be exerted over them.
Control of specific, identifiable risk factors that accelerate
atherosclerosis such as elevated lipids, hypertension and smoking,
may decrease cardiac events such as angina and infarction. Control of
these risk factors has been studied extensively (Stamler, 1983;
Castelli, 1984). Results in general have been favourable, but not
consistent or to the degree hoped for by the investigators and
controversy still exists (Brett, 1984; Corday & Corday, 1983). Risk
factor analysis and modification in patients with established clinical
ischaemic heart disease are reasonable goals, but they have not
predictably correlated with progression. In those who are followed
with serial angiographic studies (Kramer et â1, 1983; Moise et al,
1984) stenoses proximal to patent grafts, appear to progress more
rapidly, than stenoses in ungrafted arteries (Cosgrove et â1, 1981).
The development of atherosclerosis in grafts correlates best with
elevated blood lipids (Palac et â1, 1982) and vein graft patency at ten
years will probably be about 65vo (Campeau er al, 1983). It is agreed
that medical and surgical treatment does .not alter the basic metabolic
problems that cause the disease or its progression and that at present,
its therapeutic interventiorrs must be considered palliative.
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Major Factors Affecting Prognosis
Prognosis in patients with ischaemic heart disease is predicted
by left ventricular function and extent of coronary obstruction (Harris
et al, 19791' Proudfit et â1, 1983) not severity of angina pectoris.
However, if the pain pattern becomes unstable, occurrence of non
fatal infarction and death increases (Harris et â1, 1980). After
coronary artery bypass graft (CABG), the degree and duration of pain
relief and survival are related to completeness of revascularization
(Assad-Morrel et al, 1975; Buda et al, 1981), long term patency rates
(Brower et â1, 1983) and progression of atherosclerosis in native
coronary artery (Laird-Meeter et â1, 1983). The progressive nature of
the disease combined with the unpredictable role of risk factors and
modification, makes it extremely difficult to decide between medical
and surgical therapy in the individual patient.
As important as it is to control angina pectoris for improved
quality of life, it is essential that medical and surgical interventions be
timed to preserve ventricular function and thus prolong life. Needless
extension of medical therapy should not occur when non invasive
studies continue to show myocardial ischaemia and invasive studies
demonstrate proximal obstruction with distal vessels supplying viable
muscle. CABG should not be denied if indications exist and if excellent
surgical results can be obtained (l%o mortality).
Indications for Surgery
The majority of patients undergoing CABG suffer from chronic
stable angina. Symptoms maybe mild, moderate or severe. Patients
with severe symptoms should have CABG for symptom relief. In most
cases this will result in improved longterm survival (Christian et â1,
1985). In the cAss Rogistry, 29% of patients had mild or moderare
symptoms (CASS, 1983a) and has been rhe subject of greater
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controversy primarily because symptoms are usually not disabling
enough to warrant immediate CABG. Patients with single vessel
disease (CASS, 1983a) had excellent 5 yeat survival rate regardless of
medical or surgical therapy. The medical and surgical mortality rate
per yerr in this group of patients \ryas 1.4% and O.lVo respectively,
with lOTo of patients with single vessel disease eventually crossing
over to surgery during the 5 yeîr period, mainly because of
progression of symptoms to severe levels.
Patients with LAD lesions proximal to the first septal perforator
form a subgroup whose condition is more critical, because of a lack of
perfusion to a larger area of myocardium, with more frequent
occurrence of cardiogenic shock in patients who develop anterior
infarctions associated with single proximal LAD lesions, than more
distal lesions (Brooks et â1, 1982). Survival at 5 years in medically
treated patients with proximal LAD disease, is lower than those with
distal disease (9OVo versus 98Vo) (Califf et al, 1983). Delaying CABG in
patients with right, circumflex or mid LAD coronary lesions until
symptoms become severe, seems reasonable. Survival rates in
patients with two vessel disease and mild to moderate symptoms, also
showed no significant difference among those randomized to initial
medical or surgical therapy in the CASS study, and surgical mortality
rates of l.2Vo and L.OVo per year respectively. Some special
combinations, including proximal LAD lesions, have a different
outcome. Patients with three vessel disease had mild to moderate
symptoms and seemed to have no survival advantage in the medical
or surgical groups (CASS, 1983a). However, crossover to surgical
therapy was 387o ît 5 years. Again combinations involving LAD or
left main stem are indicators for early surgery.
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Asymptomatic Patients
The totally asymptomatic patients with known coronary artery
disease should not be considered lightly (Cohn er ô1, l98l; 1983a).
Thirty percent to sixty percent of patients suffer acute infarctions as
their first sign of coronary artery disease (Gordon and Kannell, l97l)
and 257o have no typical chest pain during infarction. Of patients
sustaining sudden cardiac death, almost half had no prior angina
(Gordon and Kannell, l97l). Asymptomatic patients have similar
degrees of ischaemia upon exercise testíng, as do symptomatic
patients with equal degrees of coronary artery disease (Cohn et â1,
1983b). Asymptomatic post myocardial infarction patients, in the
CASS study had equal medical and surgical survival rates of 89Vo at 5
years. In r smaller randomized trial (Norris et î1, l98l) of
asymptomatic post myocardial infarction patients showed medical
survival in patients with ejection fractions less than 0.50 after
recovery from myocardial infarction. At 5 years no patient with
ejection fraction greater than 0.50 died, but only 65Vo of those with
ejection fractions less than 0.50 were alive. It appears that impaired
left ventricular function and additional areas of jeopardised
myocardium aÍe good predictors of subsequent mortality and when
found, cABG is recommended even if symptoms are absent or
minimal (Christan er al, 1985).
Severe Left Ventricular Dysfunction
Those patients with ejection fraction less than 0.35 carry a high
medical and surgical risk (Alderman et â1, 1983). Operative mortality
reported rt 6.9Vo, with a five year post surgical survival of 68Vo
compared with 54Vo for medically treated patients. Surgery improves
ventricular function (Tchernenkov et â1, 1985) and surgery is directed
towards this cnd, often with associated procedures such as aneurysm
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plication.
Left Main Coronary Artery Stenosis
In patients with left main coronary stenosis treated medically,
only 7l7o were alive at 24 months compared with 937o for surgery
(ECSS, 1982), similar result occurred in the CASS study. This group
unquestionably are offered better longterm survival by surgery. The
syndrome of unstable angina pectoris identifies a subset of patients,
who have a. different natural history than those with chronic stable
pain patterns (Harris et rl, 1980). The definition varies, but includes,
patients with progressive anginal pain of recent onset that increases
with severity, duration or frequency, despite medical therapy; anginal
pain at rest who are admitted to a coronary care unit, but show no
enzyme changes, or an acceleration of anginal pattern that has
previously been stable and related to exertion. Readily identifiable in
reversible ischaemia is the characteristic of unstable angina and CABG
for unstable angina may provide even better longterm survival
compared with CABG for chronic angina (Cobanoglu et al, 1984). In
the CASS Registry of unstable angina, the one year mortality rate on
those operated was 5Vo and the 4 yeal mortality rate was l07o
(McCormick et al, 1983). It appears that properly performed CABG
can rgduce, by almost half, the overall 1 and 5 year mortality rates in
this high risk group of patients.
Acute Ischaemic Situations
Because eventual survival relates best to preservation of
ventricular function, increasing attention has been given to salvaging
the acutely ischaemic myocardium. Irreversible necrosis of
myocardium is time related (Pluth, 1983) and varies with the degree
of laterals to the ischaemic region (Rogers et â1, 1984). Reperfusion
must occur in less than 6 hours to allow for functional recovery, which
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is usually delayed for about 10 days (Charuzi et â1, 1984). Currenr
approaches to this problem include intracoronary thrombolysis, often
followed either by angioplasty, if the anatomic situation is favourable,
or by CABG if multi-vessel disease is present or if ischaemia persists
despite thrombolysis and angioplasty. Immediate CABG during acute
infarction can now be done safely, but resources must be well
organized to provide this treatment. The concept of immediate CABG
applies best to patients in whom infarction begins as part of
diagnostic catheterizauion (Connors et â1, 1982) or angioplasty
(Murphy et â1, 1982) and to those who have been ca¡heterized and
are in hospital awaiting surgery when infarction begins.
After infarction is complete patients may develop r variety of
well described complications that are best managed operatively.
These include post infarction angina with extension of infarction, the
development of persistent cardiogenic shock caused by ischaemia of
areas distant or adjacent to the infarction, ventricular septal defect,
mitral insufficiency as a result of papillary muscle necrosis and free
wall ventricular rupture. All of these complications carry a. high
medical mortality and surgical experience in their management is
increasing. Intravenous thrombolytic agents which can be given
immediately on arrival in the emergency room, may play a key role in
allowing earlier perfusion, while cardiac catheterization resources are
being readied (Ganz er al, 1984).
Combined CABG and Valve Replacement
coronary artery bypass surgery combined with valve
replacement surgery has increased as the technique of cardiac
surgery and myocardial protection have enabled prolonged
myocardial ischacmia (Lyrle et â1, 1983). The complexity of the
patient related variables and the operation related variables presents
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multiple issues regarding management, including the indications for
revascularization, optimal techniques of intra-operative management,
selection of valve prostheses, anticoagulant prophylaxis and the long
term efficacy of surgery. Early results looking at aortic or mitral
valve replacement with coronary artery bypass surgery suggested
that patients undergoing such simultaneous surgery had r poorer
survival than those who had only a. valve replacement performed
(Kay et al, 1984). Reports that were able to compare valve only
patients with valve and CABG that had adequate myocardial
protection with cardioplegia solutions have suggested that the risk is
not increased (Lytle et al, 1983; Cohn et al, 1984).
Although the natural history of patients with aortic valve
disease and significant coronary atherosclerosis managed non-
surgically is unknown, some data exists on the survival rate of
patients with coronary artery and aortic valve disease undergoing
only aortic valve replacement. Miller et al (1979) and Copeland et al
(1977) described an adverse influence on survival rate after aortic
valve replacement that was exerted by uncorrected coronary artery
disease. The results were based in part on r higher operative
mortality for this subset of patients. Longterm data for patients
undergoing simultaneous aortic valve replacement and bypass
grafting show at a mean interval of 22.5 months (Richardson et â1,
1979) and a 777o survival rate for survivors of surgery. Nunley et al
(1983) reported a. 697o 5 year survival rate, including death at
surgery. Lytle et al (1983) showed an SOVo survival rate at 5 years.
In the same study they rüere unable to demonstrate any effect on
survival exerted by the type of prosthesis used (ball or disc valve).
They concluded that, it can not be argued that revascularization
concomitant with aortic valve replacement might increase operative
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risk. Similar findings have also been reported when mitral valve
replacement and coronary artery surgery are performed
simultaneously (Christakis et al, 1985).
V/hile other studies have shown an increased operative
mortality when a coronary artery bypass is also performed, it is felt
this effect was due to the poor ventricular function present in the
group of patients needing CABG compared with those with mitral
valve disease alone (Magovern et al, 1985). There is no unanimity
about determinants of perioperative mortality for patients undergoing
mitral valve replacement and revascularization. Studies comparing
mortality for isolated mitral valve replacement with that for valve
replacement and bypass grafting have shown higher operative
mortality rates associated with the combined operation (Miller et al,
1978; DiSesa et al, 1982; Cze.r et al, 1984). However, it appears that
the increased peri-operative risk is caused primarily by the coronary
arJery pathology, not by the coronary bypass grafting performed to
treat that pathology (Lytle et â1, 1985a). It has been noted thar
patients undergoing mitral valve replacement and revascularization
were at increased risk, compared with patients without coronary
disease undergoing isolated mitral valve replacement, but that
patients with coronary disease who underwent mitral valve
replacement without bypass grafting had the highest risk of any of
the three subgroups (Czer et al, 1984; Chaffin and Daggett, 1979).
REOPERATION AFTER PRIMARY CORONARY BYPASS SURGERY
Following primary coronary operation, 37o of patients require
re-operation in the first 5 years (Cosgrove et al, 1986), due usually to,
early graft failure, graft stenosis or incomplete revascularization.
Later, patients may experience, progression of atherosclerosis in the
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native coronary circulation, late graft failure or a combination of the
two, which places areas of myocardium in jeopardy of ischaemia or
infarction. A study of the predictors of re-operation for 8,000
Cleveland Clinic patients who underwent primary myocardial
revascularization from l97t through to 1978, was conducted by
Cosgrove et al (1986). A total of 2.7% of the original group had
undergone re-operation up to 5 years post-operatively, however,
after 5 post-operative years the annual incidence of repeat surgery
began to increase dramatically and by the lzth post-operative year,
approximately 4Vo per year of the original group \ /ere undergoing re-
operation. Accumulative percentages of the original group who
underwent re-operation \ilore: 2.7Vo, ll.4%o, and l7.3Vo at 5, 10 and 12
post-operative years respectively.
Patient related descriptors recorded rt time of the initial
procedure and variables related to the primary operation were tested
with univariate, followed by multivariate analyses to identify
predictors of re-operation. Significant predictors of the need for re-
operation were young age (p<.0001), ûo internal thoracic artery graft
(p<.0001), incomplete revascularization (p=.0004), NYHA functional
class 3 or 4, symptoms (p=.003), normal ventricular function (p=.003),
in one or two vessel disease (p=.005). Many of these variables aÍe
predictive for long survival after primary operation, since the longer
the patient lives, the more likely a second operation becomes.
A more cogent index of untoward events after primary surgery,
is re-operation free survival. Variables identified by multivariant
testing as being associated with î decreased re-operation free
survival rate have been listed by Lytle and Loop (198s) as: no
internal thoracic artery graft (p<.0001), cigarettc smoking (p=.0001),
incomplete revascularization (p<.0001), moderate or severe left
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ventricular impairment (p=.0001), left ventricular end-diastolic
pressure >24mmHg (p=.001), systemic hypertension (p=.002), NYHA
functional Class 314 (p=.002) advanced a$e (p=.007), cholesterol
>300mg perldL (p=.008), mild ventricular impairment (p=.008), three
vessel left main disease (p=.02), and abnormal ECG (p=.03).
Significant variables exert their influences in r variety of ways.
Some descriptors ue indicative of unfavourable patient related
factors present at primary operation (advanced age, left ventricular
impairment, abnormal ECG, 3 vessel or left main stenosis, (class 3 or 4
symptoms). Others ale markers of increased rate of progression of
atherosclerosis (smoking, hypertension, hypercholesterolaemia).
Incomplete revascularization is an indicator of diffuse coronary
disease and may also reflect surgical philosophy. However, the
variable that has the strongest influence on decreasing re-operation
free survival, is the lack of an internal thoracic artery graft, a variable
that is physcian dependant. Studies of coronary bypass graft patency
have shown that internal thoracic artery grafts have patency rates
superior to those with saphenous vein grafts (Loop et al, 1976;
Campeau et al, 1983; Frey et al, 1984; Lytle er al, 1985b; Singh et al,
1983; Tector et â1, 1981). Up to 5 post-operative years there is lÙvo-
l5Vo difference in patency rate, with 95Vo of internal thoracic artery
graft patent compared to 807o-857o vein grafts, however, more than 5
years after operation the attrition rate of venous grafts increases such
that by l0 post-operative years 607o-65%o of vein grafts remain patent
and l57o-2Ù7o of those are still patent after angiographic evidence of
stenosis.
Some late vein graft attrítion is undoubtedly caused by
progression of atherosclerosis in native coronary vessels, which
decreases vein graft outflow and predisposes to subsequent graft
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thrombosis. However, in the majority of vein grafts removed at re-
operation, vein graft atherosclerosis is evident and in most cases, it is
probably these intrinsic changes in the graft that lead to stenosis and
subsequent occlusions. Internal thoracic artery grafts appear to be
relatively immune to the development of intrinsic changes and the
occurrence of internal thoracic artery graft attrition has been
documented infrequently up to l0 years after operation.
The rate of occurrence of late vein graft stenoses or occlusion is
associated with the presence of coronary risk factors. The
susceptibility of saphenous vein graft to atherosclerosis and the
association of vein graft failure and risk factors, contrasted with the
immunity of the internal thoracic artery graft to artherosclerosis
highlighted by comparing the determinants of re-operation free
survival patients who had only I vein bypass graft, with those
patients who had internal thoracic artery graft in addition to
whatever vein graft they received. Smoking, hypertension and
hypercholesterolaemia all decreased re-operation free survival for
patients who had only vein grafts, but had no influence on re-
operation free survival for patients who had internal thoracic artery
grafts (Cosgrove et al, 1986).
Indications for Re-operation
Examination of the angiographic indications for re-operations in
patients undergoing repeat surgery, looks at the same problem from
another direction. In a study of the first 1500 patients who
underwent re-operation for coronary bypass grafting at the Cleveland
Clinic, patients were graded according to whether the angiographic
indications for re-operation were: progression of the atherosclerosis in
the native coronary circulation, bypass graft failurc or both. V/hen
the patients were subdivided according to the year in which they
37
underwent re-operation, it was found that from 1967 through to 1978
only 287o of patients underwent re-operation solely because of graft
failure. Furthermore, that represented early graft failure since the
mean interval between operations was only 26 months.
Progression of the atherosclerosis in the native circulation alone
generated the need for re-operation in 557o of patients and lTVo had a
combination of graft failure and progression of atherosclerosis. The
predominance of progression of atherosclerosis in the native
circulation \ilas the cause of re-operation from 1967 through to 1978
occurred, because many patients in the early years of bypass surgery
underwent primary operation for treatment of single vessel disease
and thus were at risk of progression of atherosclerosis in coronary
vessels that had not been grafted at the first procedure. In contrast,
only lSVo of the patients who underwent repeat surgery during 1982
to 1984 had progression of atherosclerosis in the native circulation
alone, 44Vo had graft failure alone and 38Vo had both. Graft failure for
patients in the later surgical period rvas usually late, that is the
interval between operation was 66 months in the graft failure only
group and 9l months in the group with combined indications (Lytle
and Loop, 1988; Lytle et al, 1987).
Mortalitv Rates
The overall in-hospital mortality rates reported by Lytle and
Loop (1988) is 3.AVo for re-operation cases. In-hospital mortality
appeared to be caused by factors related to myocardium in 747o of
cases. Thirteen patients died intra-operatively, 16 died post-
operatively of myocardial infarction, 7 died of apparent myocardial
failure without documentation of myocardial infarction, I died
suddenly and I died of ventricular arrythmias. Nine deaths were due
to stroke and complications of mediastinotomy contributed to 3
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deaths. Other investigators have also documented an increased risk
associated with coronary re-operations. For 958 patients undergoing
operations from 1970 to 1984, Hall and associates (1986) documented
an early mortality of 88 (9.2Vo) compared with a 2.8Vo mortality for
primary revascularization operations during the same time period and
further noted that the cause of early mortality was cardiac in 8O7o of
cases.
In a review of data from the CASS study, Foster and associates
(198aa) found re-operation carried an increased risk of in hospital
mortality compared with primary surgery (5.3Vo versus 3.lVo, p<0.05).
A trend towards increased risk of peri-operative myocardial
infarction for their 283 re-operation patients (6.4Vo versus 5.87o for
primary surgery) was not statistically significant.
Long Term Results of Coronary Re-operations
In general the long term results of coronary re-operations are
not as good as the results of primary procedures. Again in Lytle's
review (Lytle and Loop, 1988) follow-up of the 1,449 in hospital
survivors of the 15,000 patient series at a mean interval of 54 months
and a range of 13 to l7l months, documented late survival of 90Vo
and 75Vo, at 5 and l0 post-operative years respectively. Mean variant
testing identified rga, hypertension, and pre-operative left ventricular
function as variables with significant independent association with
late mortality. The influences of left ventricular function and
hypertension become particularly evident more than five years after
operation. Examination of the extremes of variables show that the 3
year survival of patients over 70 years of age was 85Vo and the 5 yeal
survival of patients with severely impaired left ventricular function
was 82% indicating that even for these high risk categories re-
operation was worthwhile.
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Left main coronary artery stenosis which had a profound effect
on earlier risk and the number of coronary vessels with significant
stenoses' could not be demonstrated with multivariate testing to
influence late survival' The use of a single internal thoracic arterygraft has been demonstrated to positively affect survival afterprimary operations for bypass grafting, but as yea has not had a
demonstrabre effect on late survival after re-operation. Follow_up ofthe patients who received bilateral internal thoracic artery grafts at
re-operaüon, have so far only documenþd one late death, although
much more extensive follow-up of this promising group of patients is
needed.
Lytle (r98s) found ar 5 post operative years, approximately halfof the patients were completely asymptomatic. This was not as good aresult as for patients after primary surgery, 65vo to 70vo of whom
were asymptomatic after five post operative years (Loop et ?r, rgTg),but few patients in Lytle's re-operative series were severely
symptomaric. schaff (r gg3) also nored that a relatively highproportion of the re-operative patients had mild angina five years
after re-operation, but that severe angina was uncommon.
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2.3 METHODS OF ASSESSMENT AND THEIR LIMITATIONS
Health surveys are conducted all over the world every year
using self-administered questionnaires, telephone interviews and
personal interviews, yet there are few published comparisons of these
methods. Further, data quality is often overlooked (Gordis, 1979)
even when survey modes are compared, since the choice of mode is
often dictated by other factors such as cost, time, questionnaire
content and required response rates, and is often heavily influenced
by the study population itself. In three published mode comparisons
(Hochstim, 1967; Locander et ô1, 1976; Siemiatychi, 1979) which
considered data quality reports of mode differences varied. Hochstim
found that the 3 strategies of data collection were interchangeable
when compared according to response rates, comparability of findings,
and validity of responses, only costs varied.
Locander et al (1976) compared the three modes in asking
questions of groups of Chicago residents about voting, library card
ownership, bankruptcy and drunken driving and measured response
distortion (proportion of responses known to be false from objective
records) and found no mode differences. Siemiatychi 1979 found no
differences between mail and telephone modes in relation to item
omission (approximately 5Vo each), but so called sensitive questions
(family income and medicare number) were more readily answered in
the mail, than in telephone or home interview (face to face) mode.
Mail mode showed less reporting of physcian consultations than
telephone mode and no more than the face to face mode. A more
recent study by O'Toole et al (1986), does not fully supporr the
suggestion that data quality is affected by the mode of survey
conducted. They found a low rate of response for their mail mode,
however the poor response was confined mainly to questions about
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enviromental exposure to hazardous chemicals or activities, but good
reliability with medical questions and for these type of questions no
mode differences could be found between telephone, personal
interview and mail survey. Indeed, medical conditions which
required a medical diagnosis for subjects to be able to report them,
were more reliably answered, than conditions which required a broad
description or lay terms.
Validity of answers to medical questions varied across modes
and types of questions. Under-reporting of medical conditions was
highest in the mail mode and was lowest for conditions requiring a,
diagnosis. Over reporting was lowest in the mail mode and highest for
conditions requiring a diagnostic opinion. It is generally accepted that
the occunence of false negative responses constitutes a greater health
survey hazard than false positive responses (Meltzer and Hochstim,
l97O; Madow, 1973; Cannell et â1, 1977). Indeed false positive
responses are often ignored in published survey reports, even those
in which responses are validated.
In a study by O'Toole et al (1986), a number of the false
negative findings probably relate to the group being questioned,
which included ex-servicemen and medical questions regarding the
occurrence of venereal disease during their service history. It is
known however, that the validity of reporting of medical events
(hospitalizations, clinical physcians visits, chronic or acute conditions)
varies with the time elapse between the event and when questions
are asked (Cannell et ô1, 1977) with the impact or seriousness of the
event and with the sensitivity of the questions asked (Mork, 1970).
Issues regarding cardiac health and myocardial events tend to have a
high impact on patients with little or no embarrassment and although
the study has not been done, probably are reliably recalled and
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f eported.
Survey costs are incurred in four main areas: interviewing,
mailing, coding and office. O'Toole et al (1986), measured the relevant
contribution to costs of the three interview modes and found
telephone and home interviewing to cost approximately tOÙVo more
than the mail mode. Much of this difference can probably be
explained by the fact that the post office often has access to current
addresses and is able to redirect mail appropriately, r cost borne by
the postal service rather than the survey group.
Whatever method of follow-up is selected for patients following
coronary surgery, it must by necessity represent a compromise
between the available funds to follow-up such patients and a, wish for
precise scientific data. A blend of mail, telephone and face to face






The data described in this study represents the data collected
prospectively at the time of surgery for all patients undergoing
surgery in the Cardiothoracic Surgical Unit of the Royal Adetaide
Hospital over the preceding 25 years. This unit provides
cardiothoracic surgical services to the population of South Australia
and the Northern Territory with some patients also coming from
Tasmania. The total population base is about 1.5 million persons.
Further questionnaires were sent to all patients for whom follow-up
data was sought. The results of the combined data base of pre-
operative and post-operative information and long term follow-up
was used to answer the questions posed in the aims of this thesis.
3.2 PRE-OPERATTVE AND POST-OPERATTVE QUESTTONNATRE
This questionnaire was already in existence in the Cardiothoracic
Surgical Unit and had been used for almost twenty years. Although
much of the information it collected regarding pre-operative and
post-operative variables remained essential information, a number of
new and important variables were not included, as they could not be
foreseen at the time of the original questionnaire design. For this
reason, a ne\ry modified proforma was designed to incorporate the
vital elements of the old form (e.g. îEè, sex, time on bypass etc.) and
important ne\ü variables (e.g. model and design of prosthetic valve,
post-operative atrial fibrillation, previous angioplasty etc.). Two
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forms were designed, one suitable for all patients undergoing cardiac
surgery, a "Ca¡diac Form" (Appendix I) and if a. patient was also
having coronary surgery a "Coronary Form" (Appendix II). Data from
these forms \rras stored on a VAX computer in The University of
Adelaide and retrieved by use of SIR (Scientific Information
Retrieval) data base manager. All data from these forms was supplied
by the anaesthetist and senior registrars at the time of the hospital
admission and checked by a, research secretary prior to coding. All
data entry was performed by experienced key punch operators of the
Computing Centre in the University of Adelaide and checked, by being
doubly entered and cross verified, before being finally transferred
onto the Data File.
3.3 FOLLOW-UP QUESTTONNATRES
The period during which follow-up questionnaires were sent to
patients spanned more than eight years. The initial design of the
questionnaire was to provide a simple series of questions that would
produce reproducible reliable results. It was found that both full
response and fixed response formats were necessary. Initially a. pilot
questionnaire using the style of form chosen for isolated coronary
artery bypass patients was sent to 100 patients, their responses were
studied and slight modifications made to the original layout
(Appendix III). Although the initial format did not permit free
response r contact number was available for clarification of any
questions and this was used by 27o of respondents.
Subsequent forms used for other surveys included a mixture of
free responses (e.g. details of haemorrhage requiring hospitalization)
and fixed responses. Free responses \ilere subsequently coded with
details such as date and nature of haemorrhage being catergorized
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and checked with hospital records that were available. In the light of
experienced gained with the coronary artery follow-up form,
subsequent follow-up studies were confined to only two sides of A4
paper, as many of the patients were old and more questions proved
too difficult. Greek and Italian translations were also provided when
required.
Each form was sent with a covering letter from the Head of the
Cardiothoracic Surgical Unit, explaining the purpose of the questions
and contact personnel involved, with appropriate telephone numbers
and a reply paid envelope was enclosed. An example is provided in
Appendix Iv. After approximately four weeks, if no reply had been
received another questionnaire and covering letter was sent. If no
reply subsequently appeared, then the patient or local doctor was
contacted by telephone. If following these attempts no contact had
been made, a check was made with the South Australian Death
Register, Motor Vehicles Registration Department or Electoral
Commission.
Patients known to be alive, but for whom no response could be
obtained (e.g. overseas, senile or seen by the local doctor in the last
month, but now untraceable) were included in follow-up as alive, but
no further data included. only questionnaires answered by the
patient were included, no third party interpretation was permitted.
The actual questionnaires sent for the coronary bypass follow-up
study are seen in Appendix III; for the valve Follow-up, Appendix v;
the Diabetic Patients Following Coronary Artery Bypass Surgery,




Patients who had died during hospitalization or subsequently,
had details of their cause of death noted. This was usually based on
the cause shown on the death certificate and only rarely associated
with autopsy. While reported to be imperfect in 29Vo of cases, the
recorded cause of death does provide some indication of the cause of
death (Kircher et al, 1985). Date of death was accurately obtained for
all cases in order to conduct precise actuarial analysis. No attempt
was made to assess retrospectively the symptoms in those patients
whom were found to be deceased. Symptomatic outcome represented
in these studies relates only to those patients alive at time of follow-
up.
3.5 STATISTICAL ANALYSIS
The statistical package BMDP-81 was used to analyze data
utilizing programmes from the life table and survival functions within
the BMDP-8l series. Survival analysis included a 'Generalized Savage'
(Mantel-Cox) and 'Generalized Wilcoxin' (Breslow) both of which
needed to obtain a p< 0.05 for significance to be claimed. The quoted
significance levels were taken from the 'Generalized Savage' analysis.
For the assessment of differences between groups a pearson chi-
square test was performed. All data was analyzed in close co-




4.1 AORTIC VALVE REPLACEMENT
Introduction
Standardized prospective pre-operative and peri-operative data
was kept on all patients during the period of review (Appendix r, ID.
A follow-up questionnaire was sent to all patients whom had
undergone isolated aortic valve replacements within the
Cardiothoracic Surgical Unit, Royal Adelaide Hospital from 1963, until
lst January, 1983. The follow-up commenced mid 1983, so all
patients had at least six months since their valve surgery.
Patient Group
Complete survival follow-up was obtained on s92 patients
(98.5vo) of the 601 patients who underwenr surgery (77vo Male, 23vo
Female). Figure I shows the age distribution of the patient group
undergoing surgery.
Valve Inserted
Table I shows the valve types used during the period of review.
The Starr-Edwards group was the predominant valve type used and
was usually a non cloth covered caged ball valve, with the Bjork-
Shiley valve group being made up of predominantly equal numbers of
the monstrut and concavo-convex valves. Very few Hancock or St.
Jude valves rryere used during this period.
Hospital Mortality
Figure 2 shows the hospital mortality for 3 year cohorts of
patients during the period of follow-up with the last 3 years showing
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Figure 1 Age distribution of patients undergoing
aortic valve surgery.
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1st Decade 8.6% hospital mortality 2nd Decade 2.9% hospital mortality
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Figure 2: Hospital mortality in 2 year cohorts for





















































a hospital mortality of less than 3Vo. The figure illustrates the
dramatic fall from the first decade hospital mortality of 8.67o, to the
second decade where the mean hospital mortality was 2.9Vo. Table 2
shows the cause of hospital death in 28 patients who died during their
period of hospitalization.
Longterm Survival
The actuarial survival for the total aortic valve group compared
with an age and sex match population is shown in Figure 3. The cause
of death shown on death certificates is shown in Table 3. Longterm
survival is significantly influenced by pre-existing aortic pathology
(p<.05) (Figure 4), pre-operative dyspnoea (p<.05) (Figure 5) and
cardiac rhythm (p<.05) (Figure 6). When crude survival over the
period of review is analyzed, by valve type inserted, the overall figure
showed a significant difference (p<.02) in favour of the Bjork-Shiley
valves (Figure 7). However, in Figure 8 when factors such as the time
and learning curve associated with aortic valve surgery were
removed by considering the last decade only (the period when Bjork-
Shiley was used, ABC is the monostrut and ABP is the welded strut),
no such difference was present.
Re-operation
Table 4 shows the post-operatively determined cause of re-
operation in the total valve group. The main cause of re-operation in
the Starr-Edwards and Bjork-Shiley group was endocarditis. Of
particular interest, was the one ball variance that was found in the
Starr-Edwards group. In all, only 8 Hancock valves have been
inserted in isolation at the aortic position within the Cardiothoracic
Surgical Unit, yet six of these have required replacement.
Comolications
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Figure 3: Survival of patients following
valve replacement compared
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Figure 4: Pre:existing aortic pathology and
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Figure 5: Pre-operative dyspnoea and longterm
survival following aortic valve
replacement.
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Figure 6: Cardiac rhythm and longterm survival
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Figure 7: Survival for Starr-Edwards and Bjork-
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Figure 8: Survival for Starr-Edwards and Bjork-
Shiley aortic valve replacements during
last decade.
73 9 to
anticoagulation. Major haemorrhagic complications requiring
hospitalization in survivors (376 patients) were assessed. In all, 33
patients required hospitalization and the cause of these
hospitalizations are shown in Table 5, the dominant cause being
gastro-intestinal bleeding. Haemorrhagic complications over the
period of review occurred at a constant rate of l.OVo per annum and
this was irrespective of the prosthesis inserted. Major embolic
complications occurring in 32 patients (that is those requiring
hospitalization in the 376 surviving patients), are shown in Table 6.
Within this group the major cause of hospitalization was cerebral
vascular accidents, which accounts for 427o of admissions and 33Vo of
admissions being due to transient ischaemic attacks.
The overall rate of thromboembolic events was l.l%o per annum.
When the rate of embolic events occurring over the period of review
for the patients was assessed, a significant difference was found
between the Bjork-Shiley group and the Starr-Edwards group' after
allowing for time variables (p<.01) (Figure 9). The gfoups were not
significantly different for ôBo, sex and valve pathology at the time of
replacement. "Other complications" were described by 44 patients
(147o) and are listed in Table 7.
Discussion
Despite the continuously changing options available in prosthetic
valves, the Ca¡diothoracic Surgical Unit of the Royal Adelaide Hospital,
has tended to follow î conservative approach, preferring to use
mechanical valves of the Starr-Edwards and Bjork-Shiley type. While
modifications in these valves has occurred over the 20 year period of
review, the basic design of both valves has remained relatively
unaltered. In the comparison of the two valve types used, when no
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Figure 9: Embolic events occurring in patients
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Figure 10: Age distribution for patients undergoing
mitral valve replacement.
o
Bjork-Shiley to be a superior valve for longterm survival. However,
when insertion of a valve in the same decade was considered, the
difference was not significant. Of interest, was the improvement in
the hospital mortality associated with aortic valve replacement, falling
from 8.6Vo in the first decade, to 2.97o in the second decade and this
has been inspite of the fact that older and less fit patients have
undergone surgery in the second decade. The actuarial survival
shown for this group of patients highlights the serious prognostic
outcome for patients undergoing aortic replacement when compared
with an r1e, and sex matched population.
Death certificates, while a poor substitute for autopsy data,
showed that 4Vo of alt deaths are contributed to by endocarditis, and
emphasizes the seriousness of this complication in prosthetic valve
replacement, particularly as it was the single greatest cause of re-
operation in this group of patients. The study also illustrates that a
poor longterm outcome is associated with patients who have a worse
degree of breathlessness, aÍe suffering from aortic stenosis, and in
whom atrial fibrillation is present. \Mhy patients with aortic stenosis
and incompetence should have better survival than those with
stenosis alone is not clear, but is probably due to the time at which
they present, which with dual pathology may well be earlier than the
stenosis alone group.
These risk factors need to be considered when advising patients
for surgery. Assessment of post-operative complications, in particular
haemorrhage and embolic complications, has been confined to those
surviving. This avoids the problems of collecting retrospective data
on deceased patients. By choosing major complications requiring
hospitalization, it is possible to minimise problems of patient
recollection of the major complications, or the time at which it
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occurred. Hospitalization gives not only a documented record of
complications but also an accurate timing, permitting annual rates to
be determined. In this analysis, only the occurrence of the first
haemorrhagic or first embolic complication has been included and at
that point, the patients are removed from further analysis of
subsequent complications of r similar nature. However, very few
patients required subsequent admissions. By using this technique it
was not possible to show any difference in the haemorrhagic
complications associated with the two valves, however a significant
difference did occur between the Bjork-Shiley group and the Starr-
Edwards group for embolic complications. This has been reported by
others (Murphy et al, 1983; Dale et al, 1980; Aris et al, 1974; Miller et
â1, 1983a) and may represent a significant difference between the
valve types.
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4.2 MITRAL VALVE REPLACEMENT
Prospective pre-operative and peri-operative data was kept on
all patients. (Appendix I and II). A follow-up questionnaire
(Appendix V) was sent to all patients whom had undergone an
isolated mitral valve replacement from commencement of mitral
valve surgery at the Cardiothoracic Surgical Unit, of the Royal
Adelaide Hospital in 1963, until the lst January, 1983. The follow-up
commenced mid 1983, so all patients had aa least six months of time
lapsed since initial surgery.
Follow-uo
Complete survival follow-up was obtained on 525 patients
(98.3Vo) of the 534 patients who underwent surgery (median age 50
yoars, 43Vo Males, 57Vo Females). Figure 10 shows the age distribution
of patients at time of mitral valve replacement.
Valve Inserted
The Starr-Edwards group comprised predominantly of non-cloth
covered ball valve (3L4 patients) with 44 patients receiving a cloth
covered ball valve and 176 patients r "track" valve (Table 8). The
performance of these 3 groups of Starr-Edwards valves were initially
considered individually, but as no difference was found between them
for either pre-operative risk factors, complications or survival, they
have been presented as one group.
Hospital Mortalit)¡
Figure 11 shows the hospital mortality for three year cohorts of
patients during the period of review, with the last 3 years showing a
hospital mortality of less than 27o (The period L97l-1973 did not
have any deaths associated with it).
Longterm Survival
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Figure 1 1: Hospital mortality in 2 year cohorts
for mitral valve replacement shown as
a percentage of total operative group.
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Figure 12: Survival for mitral valve replacement
patients compared with an age and sex
matched poPulation.
Figure 12 with an age and sex matched population. The five year
actuarial survival for the patient group is 777o, compared with the age
matched group of the Australian population of 94Vo and the ten year
figures of 54% for patients undergoing mitral valve replacement,
compares with 867o in the general population. The death certificates
of the deceased patients attributed cardiac death as the dominant
cause of death (Table 9), with endocarditis accounting for 67o of all
deaths. Survival was significantly influenced by pre-existing mitral
pathology (p<.05) (Figure 13), pre-operative dyspnoea (p<.05) (Figure
14) and cardiac rhythm (p<.0001) (Figure 15). 'When survival over
the period of review is analyzed by valve type inserted, the overall
figure showed a significant difference (p<.02) in favour of the "track"
valve. However, when the factors such as time and learning curve
associated with the valves surgery were removed by considering the
last decade only (the only period when track valves were in use), no
such difference \ryas present (Figure 16, l7).
Re-ooeration
Table 10 illustrates the post-operatively determined cause of re-
operation in the total valve group. One unknown patient in the Starr-
Edwards group, was a patient who underwent replacement of the
valve overseas and details were not available from her or the hospital
concerned. Six of the eight Hancock tissue valves required
replacement.
Svmotoms
The change between pre-operative dyspnoea and post-operative
dyspnoea in surviving patients is shown in Figure 18 (p<.0001).
Complications
Atl patients with mechanical valves inserted received
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Figure L4 Pre-operative dysponea in mitral valve
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Figure 15: Pre-existing cardiac rhythm and longterm


















+ -¡ TRACK VALVES (176)
o--¡ STARR EDWARDS (NON TRACK) (321)
or23456
\
7 I 9 rO il t2 ¡3 14 15 ró t7 l8 19 20
YEARS AFTER SURGERY
Figure 16: Survival of "track" versus "non track"
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hospitalization in survivors (283 patients) occurred at a rate during
the period of review of l.2Vo per annum. Haemorrhagic complications
requiring hospitalization in the 31 patients involved is shown on
Table 11.
Major embolic complications (requiring hospitalization) in
survivors (283 patients) is shown in Table 12. All myocardial
infarctions were included in this group as were cerebral vascular
accidents (unless specifically diagnosed as haemorrhagic). Again the
rate of major embolic complications remained constant at 1.47o per
annum. Other complications were described by 6l patients (22Vo) and
are listed in Table 13. All major complications observed failed to
show any significant difference with respect to type of valve inserted,
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4.3 MULTIPLE VALVE REPLACEMENTS
Double Valve Replacements
A group of 119 patients who have undergone aortic and mitral
valve replacements were also analyzed. All of these patients were
successfully followed-up. The pre-operative parameters for these
patients were similar to the individual aortic and mitral groups.
Hospital mortality occurred in I I patients (97o). Of significance is the
longterm survival of these patients shown in Figure L9. It can be
seen that the addition of a double valve replacement does not
significantly diminish the longterm survival of these patients, when
compared to that of mitral valve only replacement patients. Further
analysis of valve type combination used, also failed to show a
significant effect on outcome (Figure 2O). The effect on breathlessness
following aortic and mitral valve replacement is shown on Figure 2t.
Eight patients underwent a mitral and tricuspid valve replacement,
with 2 hospital deaths due to ventricular fibrillation (day 5 post-
operative) and cardiac failure (day I post-operative). Two further
deaths had occurred at time of review, at 18 months post operation
due to myocardial infarction, and at 33 months post surgefy from
septicaemia.
Triple Valve Replacements
Five patients underwent triple valve replacements involving
aortic mitral and tricuspid valves with no hospital mortality. Two
patients were dead at time of follow-up, one at 49 months post
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Figure 20: Survival by combination of double valve
type used.
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Figure 2l: Change in dysponea following insertion
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4.4 BJORK-SHILEY MONOSTRUT VALVE IN THE AORTIC
POSITION
A specific revieu, was conducted of 315 consecutive patients
who had r Bjork-Shiley Monostrut inserted into the aortic position
over a four year period. The questionnaire sent to these patients is
included in Appendix V. The median time to follow-up was 23
months, range 0-46 months since operation, with 98Vo follow-up being
achieved. The patient groups comprised TOVo males and 307o females
(mean age 60 years, range 5-83 years) with 297 (947o) patients
receiving only an aoftic prosthesis and l8 (67o) having an aortic
monostrut valve plus a mitral Starr-Edwards valve. The age and sex
matched population is shown on Figure 22.
Survival
At the time of review there had been 20 (6.3Vo) deaths, with 10
(3.2Vo) of these being hospital deaths. Figure 23 shows the overall
survival for the valve group. Valve endocarditis accounted for one
late death only. The cause of death in the 20 patients is shown in
Table L4. There were no deaths in the group receiving double valve
replacements.
There rwas substantial improvement in breathlessness following
valve replacement, as indicated by the NYHA Assessment (p<.0001)
(Figure 24). Thromboembolic events that required hospital
admissions occurred in 27o of patients (Figure 25) and haemorrhagic
complications associated with anticoagulant therapy occurred in 5Vo of
patients (Figure 26). Post-operatively, only I patient required
insertion of an additional prosthesis. This was due to a. peri-
prosthetic leak secondary to infection, there had been one further







Figure 23: Overall survival of Bjork-Shiley



















































Figure 24: Change in dyspnoea following insertion
of an aortic Bjork-Shiley Monostrut valve.
TABLE L4
CAUSE OF DEATH IN MONOSTRUT GROUP
Cause
Hospital Death
























































Figure 26: Haemorrhagic events occurring in Bjork-

























The Bjork-Shiley 600 convexo-concave tilting disc valve released
in 1976, remains a commonly used prosthesis and improvement in
flow characteristics has been achieved by increasing the opening
angle to an optimal 700 (Bjork, 1937). The 7Oo convexo-concave
model was released in 1980, but subsequently withdrawn due to
outlet strut fractures (Ostermeyer et rl, 1987). The monostrut model
became available in 1982 and incorporated the advantages the
convexo-concave disc, a 700 opening angle and a stronger outlet strut
fashioned, as an integral part of the valve ring. No strut fractures
have been reported in over 5,000 valve replacements for this model
(Thulin et al, 1988). Its longterrn success will depend on close follow-
up of all patients in whom it is inserted. Embolic complications and
haemorrhagic complications appear to occur at a. similar rate to the
non monostrut predecessor.
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4.5 TRENDS IN VALVE SURGERY IN SOUTH AUSTRALIA
1960-1985
A 25 yea1- experience of open heart surgery at the
Cardiothoracic Surgical Unit at the Royal Adelaide Hospital was
assessed. The unit serves a largely homogenious caucasian population
of approximately 1.5 million people. From 6 operations in 1960, the
number rose to 1,256 in 1984, with a total of 12,165 open heart
pfocedures being performed in the 25 yeaf period. Valvular sufgery
has shown a, small but steady increase throughout the period of
review, from 229 mitral valve replacements in the first l0 years, up
to 362 during the last decade (Figure 27). A similar trend is shown
with aortic valves, although an increasing proportion of aortic valves
inserted have been in combination with coronary altefy bypass
grafting, with 33Vo of aortic replacements in 1984 also having a
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Figure 27: Change in the number of patients
undergoing mitral valve surgery over 25
years.
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Figure 28: Change in the number of patients
































CORONARY ARTERY VEIN GRAFT SURGERY
5.I THE FIRST TIryELVE YEARS
Coronary artery bypass grafting is now the most common major
surgical procedure performed in Australia. It is therefore important
that the efficacy of the operation is kept under review. This review
covers coronary artery bypass grafting performed in South Australia
over a twelve year period to December 31st, 1981. Previous reviews
of such operations in South Australia \Ãrere conducted in 1976 and
1979 (Craddock et rl, 1977; 1980). The first coronary artery graft
operation in this State was performed in December, 1970 and 4,001
patients have undergone isolated coronary artery grafting to
December 31st 1981. Patients who have had valve replacements or
resection of left ventricular aneurysms in addition to coronary artery
grafting have not been considered in this study. No patient in this
study or subsequent studies described in this thesis have undergone
internal mammary artery bypass grafting. South Australia has a
population of 1.35 million people and the Royal Adelaide Hospital has
the only Cardiothoracic Surgical Unit in the State. A small number of
patients were referred for treatment from other States of Australia




An overall follow-up rate of 98.87o \üas achieved with only 48
patients being untraced at time of review in June, L982. These
patients had either moved interstate and could not be located, or had
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changed address and failed to continue with any medical supervision
after surgery. Patients who underwent a second operation \ilere
considered as two separate patients. In the first instance, follow-up
ceased at the time of the second operation, the second operation \ilas
then taken as the time of commencement of follow-up of the "second
patient".
The mean period of follow-up is 3.1 years for the total group'
the age and sex distribution of the patients undergoing coronary
artery grafting is shown in Figure 29. The percentage of women
presenting for surgery has gradually increased from 57o in L972, to
17.67o in 1981. Women comprising l4.8Vo (592 patients) of the total
operative group. There has been r steady increase in the average age
of patients undergoing surgery during the 12 years of review. In
1971, the mean a1e was 44 years, but by 1981 it had risen to 57
years (Figure 30). Of the 4,001 patients, 3,852 (96.37o) had undefgone
the operation for chronic or unstable angina.
The differentiation between these classifications is not always
easy and depends on the definition of unstable angina, however, l07o
of the patients in this group had recurrent pain at rest before the
operation. The remaining 148 (3.7Vo) patients were operated on for
other feasons, of these, a. small group of 49 (1.27o) had no symptoms.
They had been investigated after an infarction and their angiograms
were considered to be sufficiently abnormal for an operation to be
recommended on prophylactic grounds. A further 84 (2.lVo) patients
had a second operation because of recurrent symptoms, this left 15
(0.77o) patients with indications such as tachyarrhythmias (5 patients)
or acute myocardial infarction (10 patients). It was not a general
policy of the Unit to operate for acute infarction, but these were
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Figure 29: Age and sex distribution of total coronary
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Figure 30: Mean age of patients at the time of
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The number of operations performed
each year of review shown by the
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Figure 33: Mean duration of cardiopulmonary
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Figure 34: Survival pattern of the operative group
compared with an age and sex matched
group for the Australian population. The
percentage of patients surviving at the
end of each 12 month period are shown
on the bottom line.
suitable for emergency operation.
The total number of procedures has increased each year (Figure
31). The associated hospital mortality has fallen from 5Vo in 1974, to
less than l7o for the years 1980 to 1981 (Figure 32). The hospital
mortality for the total group was 1.47o. The number of grafts inserted
per patient has increased from a mean of 1.3 in 1971, to a mean of 3.1
in 1980 and 1981. Triple vessel grafting (Figure 32) was performed
most frequently in 1981, with quadruple grafting being next in
frequency. Despite this increase in the number of grafts per operation
the mean duration of cardiopulmonary bypass fell from 113 minutes
in 1973 to 5l minutes in 1981 (Figure 33). Peri-operative infarction
was defined as the appearance of the new Q waves in the ECG in the
immediate post-operative period. In the total operative group peri-
operative infarction by this definition occurred in 2.6Vo of patients and
in 2.4Vo of the 1028 patients who had undergone operation in 1981.
Survival
There were 48 patients with whom no specific contact could be
made, these were presumed to be alive as no record of death was
found in South Australia or other Australian States. However,
survival time was calculated only until the last documented visit to a
local medical officer or cardiologist, the remaining 3,953 patients were
either known to be alive a¡. the time of follow-up, or the dates of
death were known.
The one year survival figure for the total group of patients was
97Vo and the five year figure was 917o. Figure 34 shows the survival
for the total operative group compared with an age and sex matched
population drawn from the lifetables of the Australian population
(Australian Bureau of Statistics, 1981). The small number of patients
operated on in the early part of the series makes the interpretation of
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survival analysis for those years difficult. Potential risk factors which
may have influenced survival were analyzed. The risk factors which
did not reduce longterm survival in this study were: age (in women),
sex, the year in which the operation was performed, the number of
grafts inserted, the presence of moderate impairment of left
ventricular function, diabetes, hypertension, unstable angina or the
use of cardioplegia. The factors which did produce significantly
reduced survival time wers: poor left ventricular function (as
diagnosed by chest x-ray films, left ventricular angiography or
marked elevated left ventricular end diastolic pressures), increasing
rge (in men), peri-operative infarction or multiple pre-operative
infarctions, a second operation and a, prolonged period on
cardiopulmonary bypass.
Symptoms
The mean follow-up period was 3.1 years at the time of review.
Seventy percent of surviving patients reported complete relief of
symptoms and 23Vo reported partial relief. Angina was therefore
absent or substantially reduced in 93Vo of surviving patients at time of
review. This is a similar figure to that found in patients who survive
5 years after operation, when 93Vo of survivors were either free of
angina or substantially improved (Figure 35). When angina did recur,
it recurred in 59Vo of patients within the first post-operative year.
An attempt was made to assess shortness of breath in the same
way as angina. This is a more subjective symptom than angina, it is
not always possible to differentiate between cardiac and pulmonary
disease as r cause of shortness of breath. A total of 77Vo of the
patients suffered from shortness of breath before operation, but only
437o of patients complained of this symptom at follow-up. In the
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Figure
worse in 207o of patients. When shortness of breath recurred after
the operation in the majority of patients (68Vo) it recurred within the
first post-operative yeaf. The pattern of subsidence of symptoms of
breathlessness was therefore similar to the pattern of decrease in
anginal pain. Activity was the third parameter used to gauge the
symptomatic outcome. Of the 3,722 responses received, TlVo of
patients described their level of activity after the operation as
improved, Zl%o thought their level of activity was the same and 8%
thought that their level of activity was less. There was î significant
association between improvement of activity and decrease in angina
(p<.001).
Visit to the Doctor
Forty-four percent of patients stated that they visit their doctor
less often after the operation, 67o have not Seen a doctor at all, 207o
required more frequent visits, and 3O7o visit the doctor as frequently
as before the operation. No attempt was made to classify the causes
of the patients visits to the doctor into catdiac and non cardiac
categories.
Smoking
Reported smoking patterns changed dramatically after the
operation, whereas 507o of patients smoked before the operation, only
2l7o of patients smoked after the operation. Of the total patient group
16%o smoke less, 4Vo smoke the same amount and l7o have increased
their consumption of tobacco. A significant association exists between
smoking before operation and recurrence of angina (p<.05), however,
no significant association was found between smoking after the
operation and the recurrence of anginal pain.
Discussion
A number of interesting trends were revealed by this 12 year
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review. A steady increase in the mean age of patients undergoing
surgery, probably indicates a. liberalization of selection criteria as the
procedure has become accepted and established. A fall in hospital
mortality has been associated with an increased number of patients
proceeding to surgery. The unusually high mortality in 1974 (5 of
105 patients), was due in part to 3 deaths from pulmonary embolism
and action taken to overcome this problem produced an immediate
reduction in hospital mortality. Shorter periods on cardiopulmonary
bypass, despite an increased number of grafts inserted in each
operative procedure, n?y have contributed to a falling rate of hospital
mortality. An increase in the number of grafts in each patient has not
altered the mortality rate of the operation, it is expected that
increasing the number of grafts in each patient will reduce the
number of recurrences. Consideration of survival after coronary
artery surgery is difficult, as appropriately matched medical control
groups are not obtainable because of great symptomatic benefits
provided by operation. Other studies have attempted to match
medical and surgical groups (Varnauskas et â1, 1980; Hammermeister
et â1, 1979b), but this study has confined comparison to life tables of
the Australian population. These tables include not only persons free
of heart disease, but also those suffering from terminal conditions, a
factor which may introduce some bias.
It has been suggested that a, truly comparative group would be
those granted insurance policies which excludes those terminally ill
people (Chait, 1982). In contrast to earlier reports (Craddock et â1,
1977:' Craddock et ô1, 1980) which assessed hospital mortality against
risk factors, the sex of the patient was not found to be a fact in
longterm survival, however, this may well reflect the relatively small
number of female patients included in this study. The year in which
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the operation was performed also failed to influence the survival rate.
Increasing surgical experience probably compensated for the selection
of older patients in more difficult cases in the latter years reviewed.
The a1e of female patients \ilas not a significant survival factor, but
there were relatively small numbers of these patients in each 5 year
cohort analyzed. It is reasonable to suppose that the age at time of
operation would have some bearing on length of survival and this is
true in elderly male patients who have a. significantly shorter survival
than do other patients. As has been shown in other series (Crossgrove
et rl, 1982: Zubiate et al, 1977) poor left ventricular function,
significantly reduced post-operative survival regardless of the
method of assessing left ventricular function. The occurrence of
multiple pre-operative infarctions similarly reduced survival. In
some series peri-operative infarction has not been associated with a
decreased longterm survival (Codd et al, 1978). This was not the case
in this study and other published studies confirm this finding (Namay
et â1, L982). The definition of peri-operative infarction as the
presence of a new a wave may explain these apparently contradictory
findings, such a definition selects a more severely affected group of
patients than those in series which use enzyme changes and other
minor ECG abnormalities, as criteria for the diagnosis of infarction.
The rapid recurrence both of breathlessness and of angina in those
whose symptoms recur after operation, may be explained by failure
to revascularize the myocardium adequately, either because of poor
distal arteries or technical problems, the former reason seems more
likely to apply in more experienced units.
One of the alleged advantages of coronafy artery grafting as
opposed to medical management is that the patient no longer requires
the same degree of medical supervision after surgery. This study
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supports such a, view, especially as the data would tend to
underestimate the improvement in the condition of these patients,
because no account has been taken of other medical problems which
might require medical supervision after the operation. A somewhat
inexplicable finding on these results is the lack of effect of diabetes on
the outcome following coronary artery surgery. This is at variance
with other reports (Salomon et al, 1983; Devineni and McKenzie, 1985;
Johnson et â1, 1982b; Lawrie et â1, 1986) and was a stimulus to
further study reported elsewhere in this section.
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5.2 COST AND BENEFIT TO THE COMMUNITY OF CORONARY
ARTERY BYPASS GRAFT SURGERY
With the emergence of coronary artery bypass grafting as an
established procedure to treat myocardial insufficiency, there has
been a dramatic increase in the number of cases performed annually
in centres in Australia (Figure 31) as elsewhere in the world (Loop et
al, l98l). This change has carried with it, an increasing initial cost to
the community in general and governments in particular. There have
been some attempts to assess the financial implication of such surgery
in the USA, England and Australia and these studies have suggested
the procedure is extremely cost effective. Such assessments are
complex and should include consideration of the cost of the procedure,
impact on employment (Love, 1980), extent of ongoing medical
supervision and the associated mortality and morbidity (Oberman and
Kouchoukos, 1979; Niles et al, 1980; Russell et î1, 1980; Anderson et
â1, 1980; Barnes et â1, 1977; Symes et â1, 1978; Smith et â1, L982;
Oberman et â1, 1982; Hammermeister et â1, 1979a; Johnson et al,
1982; CASS, 1983b).
All of these parameters have now been assessed in 4,001
patients who underwent isolated coronary artery venous grafting
over a 12 year period defined in the previous section. The
questionnaire sent to these patients was the one shown in Appendix
IIII. Specifically, surviving patients, were asked to categorize their
employment prior to surgery as either working full time, working
part time, retired, government supported pension, unemployed or
independant, and then under the same heading their employment at
the time of follow-up. In order to include performance of home
duties a question was designed to ask housewives, not otherwise
employed, to describe the level of home duties they performed as full
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home duties, part home duties, no home duties, both prior to
operation and at time of follow-up. Patients who were not employed
prior to their operation were asked to categorize the reason, using the
options of either âgo, heart problems, other medical reasons,
employment redundancy, voluntary retirement, community attitudes
to their heart disease, poor job opportunities. A similar question was
also required to be answered at time of follow-up if they remain
unemployed.
Procedure Cost
To obtain some indication of the cost of coronary artery grafting
within the hospital, the aid of Finance Division and the relevant
departments serving the Cardiothoracic Unit, were contacted to
itemize costs incurred by the Unit during the 12 month period
corresponding to the financial year 1981 to 1982. This information
along with the total number of patients admitted to the unit, was used
to determine the average cost of coronary artery grafting per
operation (Table 15). This technique makes it impossible to build in
depreciation costs of buildings and major equipment although items of
equipment purchased during the relevant financial year are included.
Details of this financial data appear in Appendix VIII.
Employment
The impact of coronary artery grafting on employment is
complicated by the fact that the mean age of the group was 54 years.
The largest 5 year cohort for males was the 50 to 54 a5e group (834
patients) and for the females the 55 to 59 age group (140 patients).
Figure 30 shows the age and sex distribution for the total group. The
older age group encompasses a. large proportion of patients more
likely to retire from the work force irrespective of the cardiac disease.
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those employed at follow-up would not take into account the normal
attrition from the work force with a5e. The retirement data for the
general male Australian population is only available for 5 year age
groups of 50-54 years, up to 60-65 years (Australian Bureau of
Statistics, 1982). For the purpose of comparisons the male patients
who underwent coronary artery grafting were divided into similar
groupings. Figure 36 demonstrates how the full time male pre-
operative employment pattern relates to the full time male Australian
employment.
By calculating the mean period of follow-up for each age group
in each cohort of patients and assuming the male Australian
employment pattern was unchanged during the period of review, the
pattern of fult time employment rt time of follow-up is shown in
Figure 37. The change in full time employment as a percentage of the
total male operative group shows a, consistent downward trend of
about 4Vo when compared with the post-operative pattern (Figure 38).
However, the shape of the pre- and post-operative full time
employment curves aÍe similar for both the operative group and the
general Australian male population.
V/hen home duties are used as an index of employment the
improvement between pre- and post-operative employment is
marked. Of the 430 females who responded, 377o were on full home
duties, 55Vo on part home duties and 87o on no home duties pre-
operatively. At the time of follow-up, 687o had returned to full duties,
3OVo could manage part home duties and only 27o were on no home
duties.
Pattern of Emolovment
Figure 39 outlines the changes in unemployment and the
reasons given for these changes in 866 patients prior to surgery and
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Figure 39: Reason given by patient for
unemployment before and after
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Figure 40: Survival curve for the first 500 coronary
artery bypass patients compared with an
age and sex matched PoPulation.
1,414 patients at time of follow-up. A significant shift has occurred in
"Heart" with an ll%o fall. However, poor job opportunity and
community attitudes show a SVo rise. Voluntary retirement and other
medical reasons accounted for 8.57o drop. Figure 39 also illustrates
how a distorted view of the operation can be obtained if
unemployment figures are not corrected into the normal retirement
patterns. Thus there was an overall increase of 163%o in
unemployment at follow-up when compared with the pre-operative
group.
Average Cost of Operation
The determination of this figure is based on a number of
assumptions. Where possible the costs of running the wards and
theatres used by the Cardiothoracic Unit have been added and divided
by the number of patients admitted per yoar. Since items such as X-
rays and anaesthetics cannot be costed in this fashion they have
therefore been allocated on the basis of "typical" patient. Table 15
shows the breakdown for the contributing sections of the cost. No cost
has been attributed to angiographic investigation and its attendant
expense, as these are usually performed some weeks earlier, but
could be added to give the total cost.
Discussion
Few previous studies have attempted to address the issue of the
cost to the community and individuals of coronary artery bypass
surgery (Love, 1980; Oberman and Kouchoukos, L979; Niles et î1,
1980; Russell et â1, 1980). Changes that occur before and after
surgery ate more controversial. The questionnaire used was simple
and involved î fixed format. However, patients did have a contact
telephone number they could use to resolve problems, but only 2Vo of
respondents made use of this facility. The overall pattern of male
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pre-operative employment is similar to that of the general male
Australian full time employment pattern. Unfortunately the details of
Australian female employment are not available. In our group,
however, only l57o of patients were female. Only working women
were missed and this represents less than 4Vo of the total group. The
post-operative employment pattern again showed the male patients
to follow a simila¡ pattern to the general population group, but with a
downward translation. This downward translation is clearly
illustrated in Figure 38, where the pre-operative pattern was
approximately 4Vo more employed than the equivalent îge corrected
post-operative group.
One possible bias with this data was that pre- and post-
operative information was obtained on survivors only at the time of
follow-up. No retrospective assessment was made of employment
behaviour of non survivors. It seems reasonable however, that those
currently living are a representative sample of those leaving hospital,
as the study includes longterm and short term patients. Reports have
appeared showing no significant difference in patient employment
pattern after surgical and medical treatment (Hammermeister et â1,
L979a), as well as significant differences (Russell et â1, 1980). It is
not possible to answer this in this study, as no appropriate control
group exists. However, this study confirms that coronary artery
bypass grafting has a slight effect on work performance.
Justification of intervention on symptomatic grounds should
therefore not be weighted by dropout from the workforce. The main
reason for giving up work was given as "heart" pre-operatively and
"age" post-operatively. The percentage of patients unable to work
due to "heart" post- operatively fell by more than one third. Of
greatest concern was the group of patients who thought their
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unemployment was due to "community attitude". They represented
47o of the post-operative group, which was a. rise of 3.57o from the
pre-operative group percentage. This group possibly could be helped
by improved employer and community education.
One aspect of the cost differential between coronary artery
bypass grafting and medical management that should not be ignored
is the ongoing dependence on the medical profession of the patients
concerned. This study clearly shows that 50Vo patients see the doctor
less than before surgery. This has savings not only in consultations,
but also in pharmaceutical dispensary and laboratory investigations
that frequently attend medical consultations. Further, the age group
under consideration has not infrequently concommitant medical
problems unrelated to their cardiac disease. We have not asked the
patient to judge whether the visit is related to cardiac disease
however, it would be reasonable to assume that many visits may have
a. non cardiac basis on the basis of the high percentage cure of the
cardiac complaint by coronary artery bypass grafting, which is
indicated by the improvement of angina and breathlessness.
Others have shown that following discharge from hospital, costs
for surgical patients are more than for medical patients (CASS,
1983b), however, their study group had admission to hospital
routinely in the first 12 months, a routine that was not a feature of
our patients. The cost of the operation at about $3,500 (1981 prices),
has been possible due to a considerable economies achieved because
of the high surgical throughput. Although, it must be noted that
depreciation has not been calculated. To put this cost into context the
average male full time wage in Australia in 1981-82 was $15,934-10
which would incur a Federal Income Taxation in excess of the
operative cost, thus if a male is able to return to work for one year
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following operation then operative costs are recouped.
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5.3 THE TEN YEAR OUTCOME FOLLOWING CORONARY ARTERY
SURGERY
The first 500 patients to undergo coronary artery bypass graft
surgery were followed up at least 10 years after initial surgery to
assess their current level of health, to determine factors that influence
long term survival, to identify the risk factors that may influence re-
operation and to assess outcome for those patients requiring re-
operation. The group comprised 500 patients, 453 males (9lVo) and
47 females (9Vo), with a mean follow-up of 11.5 years (range 10-15.5
years) with a 98Vo follow-up. The overall group survival is shown in
Figure 40 compared with an îEe and sex matched general population.
The time at which surgery was performed did not significantly alter
outcome (i.e. first 100 cases cf last 100 cases) (Figure 4l). Similarly,
male and female patients had similar long term survival with no
significant difference although the number of female patients was
small (Figure 42). The survival obtained for male and female patients
compared with an age and sex matched population is shown in Figures
43 and 44. Factors which did significantly alter long term survival
were previous myocardial infarction (p<.0001) (Figure 45), diabetes
(p<.01) (Figure 46), hypertension (p<01) (Figure 47) and abnormal
myocardial contraction (p<.01) (Figure 48).
Svmotoms
In 315 patients surviving at time of review, 64Vo described their
present level of activity compared with their pre-operative level of
activity as "better", in l9%o "the same", and "worse" in llVo.
In the same surviving group, 48Vo described "no" breathlessness
after surgery, 277o said it was "less" than prior to surgery, l37o "the
same" and lLVo now felt it was "\Ãrorse" than pre-operatively.
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Figure 4l: Effect of time of surgery on longterm
survival in the first 500 coronary artery
bypass patients.
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Figure 42: Influence of sex on survival for the first
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Figure 43: Male longterm survival compared with
the general population in the first 500
coronary artery bypass cases.
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Figure 44: Female longterm survival compared with
the general population in the first 500
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Figure 45 Influence of previous myocardial
infarction on survival in the first 500
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Figure 48: Influence of myocardial
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coronary artery
by 3L6 surviving patients: 4LVo had no angina, 40Vo had "less" angina,
L2Vo "the same" and lVo now had "worse" angina.
Redo Patients
Within the first 500 cases, 8l patients had required a further
operation when followed up. In the first 100 cases 207o had further
surgery, l97o in the second 100, 13% in the third 100, 167o in the
fourth 100 and l37o in the last 100 cases. When the overall survival
for re-operative and non-reoperative patients is considered, re-
operative patients appear to have a survival advantage (Figure 49)
(p<.001). However, this probably represents the fact that they had a
return of symptoms that warned recurring myocardial insufficiency
and were fit enough for further surgery and therefore represents a
highly selected group. However, when survival from time of redo
surgery is considered, compared with survival from the initial group
who did not have redo surgery, a significant difference emerges
(p<.02) (Figure 50). \Vhen the hospital mortality is removed from the
analyses (Figure 51) no such difference occurs. This indicates that if
the peri-operative and hospital mortality is reduced then redo
patients have the same longterm survival outcome as patients
undergoing only their first operation.
Other factors analyzed that may have led to the occurrence of
redo surgery (sex, diabetes only I patient, hypertension, previous
myocardial infarction and impaired myocardial contractility), failed to
be more prevalent in the redo than in the non redo group however,
the redo group is a small sample and it was unlikely that any single
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Longterm survival for patients requiring
re-operation from those operated on in
the first 500 cases of coronary artery
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Figure 5l: Re-operative group survival compared
with non re-operative group survival
after hospital mortality has been
excluded.
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Figure 52: Annual nu-mber of redo coronary artery





5.4 RESULTS OF RE.OPERATION FOLLOWING CORONARY
ARTERY SURGERY
Re-operation for coronary artery disease is becoming an
increasing and difficult challenge (Figure 52). Over the first 14 year
period, 136 patients underwent redo surgery within the
Cardiothoracic Unit of the Royal Adelaide Hospital, representing an
overall rate of 27o. The mean interval between operations was 56
months (range 0-138) (Figure 53) and between the second operation
and follow-up 32 months (range 2-120). Hospital mortality for the
second operation was SVo (Figure 54), with an overall mortality at
follow-up of l3%o (8 cardiac, 8 hospital, I CVA). This compares poorly
with the total operative group mortality of between l-2%o, but is
consistent with other early reported results for redo CABG (Winkle et
â1, 1975; Tyson et â1, 1978; Reul et al, 1979; Thomas et al, 1976:
Norwood et â1, 1977; Oglietti et rl, 1976; Wukasch et â1, 1977;
Culliford et â1, 1979). The number of grafts inserted initially was
2.5lpatient and at time of subsequent surgery l.9/patient compared
with 3.l/patient for the total group. Between the two operations 24Vo
of patients underwent a myocardial infarction. All patients developed
recurrent angina prior to redo surgery.
Amongst the survivors of the second operation, at the time of
follow-up angina was improved in 9O7o and shortness of breath in
84Vo. Activity was described as better in 6L7o and the same in 207o.
Further hospitalizatíon for cardiac problems was required in 29Vo
following the second operation and 6lVo of patients required cardiac
medications at time of review. Prior to the initial operation, 54Vo
smoked compared with 23Vo at time of second operation and only 97o
at the time of follow-up after the second operation.
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Figure 54: Annual mortality obtained for first and
redo coronary artery bypass graft
patients.
operation, nor was the sex ratio significantly different from the
general operative group.
To try and assess some possible angiographic risk factors that
may contribute to re-operation, the angiograms of the first 4l
patients that underwent re-operation were analyzed in detail by a
"blinded" cardiologist. This redo group represented a typical subset of
the total patient pool, with the mean ages over the period of surgery
of the first 4l redo patients, being the same at 54 years. The sex
ratios were identical, occupation and activity were also similar. The
redo group showed a higher percentage of reformed smokers at the
time of second operation and a TOVo drop in heavy smoking with the
first operation. The incidence of diabetes and hypertension was not
significantly different. The operative mortality for the first 4L
patients was a high 7Vo, however, this represented only 3 deaths in all
and it is difficult to make any useful inference in this small group.
However, these deaths occurred early in the experience and it may
represent the learning curve associated with redo surgery. The time
course betwoen the first and second operation has also been
calculated and shows a bimodal distribution with an early peak in the
first lZ months, followed by a characteristic normal distribution
around 4 years post initial symptoms.
By review of the angiograms available on these patients prior to
the first operation and prior to the second operation, the possibility of
technical fault was sought. In 4l patients reviewed retrospectively,
only I could be directly attributed to a poor technical procedure.
Another possible cause leading to redo is failure to treat
significant lesions at initial operation. This is difficult to assess,
particularly when one considers many redo patients had their first
procedure when coronary artery bypass graft was in its infancy and
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only severe disease was considered worthy of bypass. Lesions of 5O7o
or more are now routinely bypassed, however, review of all available
angiograms prior to the first operation revealed an additional 18
vessels would have been grafted by current criteria and this may
have meant a, reduction of 7 in the number of redo cases
subsequently performed.
The more controversial factor alleged to influence coronary
artery graft success is the quality of distal runoff vessels. Poor
vessels are suggested to be more likely to cause graft failure than
healthy ones associated with an isolated disease area. To consider
this, all 4l patients had their distal disease graded at time of initial
angiogram as good and free of distal disease, mild distal disease,
moderate distal disease, severe distal disease. This was correlated
with the ultimate graft outcome. Of the 72 grafts performed initially,
35 had blocked at time of re-operation and 4 were severely stenosed
(9OVo+¡. Of these, 50Vo were present in hearts where the distal vessels
were graded as having mild, moderate or severe distal disease.
However, 50Vo of those with distal vessels graded as good, had blocked
or stenosed grafts.
When the number of patients with blocked grafts was
considered, 547o had been graded as good were found to have blocked
grafts, with 53Vo graded as diseased were found to have blocks, this
failed to illustrate distal vessel disease as a significant factor to
distinguish the two groups. Even when allowance was made for
possible technical causes for graft failure likely to be present in the
first 12 months, the difference was still not significant.
Discussion
These results on a small number of patients are similar to those
reported by larger reviews (Fitzgibbon et î1, 1986; Bouragassa et â1,
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1984), which failed to identify angiographic risk factors predictive of
subsequent re-operation othe r than technical or inadequate
revascul arization.
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5.5 CORONARY ARTERY BYPASS SURGERY IN PATIENTS
WITH DIABETES MELLITUS
The Framingham Study (Castelli, 1984) demonstrated in diabetic
subjects that the relative risk of coronary artery disease was
increased approximately two fold in males and four fold in females
compared with matched non diabetic subjects. It has been reported
that diabetics have more extensive atherosclerosis and increased
prevelance of cardiac failure and a poorer prognosis following acute
myocardial infarction. In longterm studies, up to ten years following
myocardial infarction, diabetics have been shown to have a two fold
increased in relative risk of death compared with non diabetics.
It is surprising that review of the relevant literature reveals
little information on the outcome of coronary artery surgery in
patients with diabetes mellitus who have coronary aftery disease.
The aim of this review was to assess whether the presence of diabetes
mellitus imposed an additional operative risk in patients undergoing
coronary rrtery surgery in South Australia and whether or not this
risk was related to the sex of the patients or the nature of the diabetic
therapy they were receiving. The earlier review of the first 4001
cases had failed to show it as an independent risk factor, so this study
was conducted 7 years later, on r larger patient group with a longer
period of follow-up.
Patient Group
Diabetes mellitus has been reported by others as a. significant
independent risk factor in the development of coronary artery disease
and between 5 and lÙVo of patients undergoing coronary artery
bypass graft surgery suffer from diabetes mellitus (Salomon et â1,
1983; Devineni and McKenzie, 1985; Johnson et al, 1982; Lawrie et al,
1986). Several reports have demonstrated that such patients have an
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increased hospital mortality as well as r reduced longterm survival.
Within the Cardiothoracic Surgical Unit at the Royal Adelaide Hospital,
the average age of diabetic patients and non diabetic patients at time
of review was identical (57 years). However, the malel female ratio
showed twice the number of females in the diabetic group when
compared to the non-diabetic group.
The diabetic patient presented with unstable angina in líVo of
cases, compared with lÙVo for the non diabetic group (p<.01).
Although prior myocardial infarction was the same in both groups,
diabetics had more evidence of ischaemia and anterior chest lesions,
237o versvs I77o (p<.OL). Localized stenoses greater than 7O7o in major
coronary arterial systems such as the left anterior descending
marginal and the right main arteries, were higher in the diabetic
subjects (p<.05) and the number of grafts in diabetics was greater
than was non diabetics, 2.9 versus 2.6 (p<.01), with the hospital stay
identical in both groups. What is not clear, is the role of therapy that
the patient is receiving or differences between the sexes.
This study was designed to assess the early and late outcomes
for 561 consecutive patients operated on in the Cardiothoracic
Surgical Unit of the Royal Adelaide Hospital, with a diagnosis of
diabetes mellitus, between l97l and 1988, with respect to the type of
diabetic therapy they were receiving at the time of surgery.
Results
The total patient group during this period was 10,506 patients,
of which 5Vo were diagnosed as suffering from diabetes mellitus. The
total follow-up was 97Vo and was achieved with only 17 patients being
lost to complete follow-up (mean follow-up 5.6 years). The overall
hospital mortality for the total coronary artery bypass graft group
during this period was 1.3%, representing 137 deaths in a total patient
II3
group of 10,506 patients. Within the diabetic group which comprised
SVo (561 patients, 435 males, 126 females) of the total operative
group, the 30 day mortality was 4.8Vo. Although not significant, the
male 30 day mortality was 4.27o, with the female group being 6.3Vo
(p=.058) (Table 16). The total number of deaths in the diabetic group
was 124 (217o) over a mean period of follow-up of 5.6 years (range 0-
l7 years).
When the type of diabetic therapy being taken by the patient
was considered, the group comprised 247o on diet alone, 467o on
tablets and 3O7o on insulin. The age of the patients undergoing insulin
treatment from within the male group was significantly younger
(p<.004), but this was not a signifÏcant difference in the female group.
Figure 55 shows previously documented actuarial survival curves for
the 4,001 coronary artery bypass patients and the results from this
study for the diabetic patients when divided into male and female
patients. There was a, significantly reduced overall survival for the
female patients (p<.05) when compared with male patients.
When the treatment being received by each group was assessed,
male patients showed no significant difference between diet, tablets
and insulin (Figure 56). Diet controlled male patients tended to have
a reduced late survival. Female patients however, had a reduced
survival if they had diet controlled diabetes (p<.05) (Figure 56),
despite no significant difference in age or other variables between the
female subgroups. Furthermore, the 30 day hospital mortality for
females showed a similar trend, with none of the insulin controlled
patients dying, but 3 of 20 (157o) diet controlled and 5 of 60 (8.17o)
tablet controlled diabetics dying. This was not significant (p=.058).
The female group showed no significant difference from the
















MALE FEMALE P VALUE
57 years 57 years P = n.s.
4.3Vo 6.87o p < 0.058
27Vo 35Vo P = n.s.
267o 167o P = n.s.
47Vo 49Vo P = n.s.
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Figure 56: Outoome for male and female patients
classified by type of diabetic therapy
received.
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ventricle, other cardiac pathology or smoking habit at time of surgery.
In faú on angiogram, chamber size was generally smaller than males
who had smoked more in the past (Table 16). Females did however,
have a. higher rate of hypertension and an increased incidence of
cerebral vascular accident (Table l7) and at the time of surgery had
an increased incidence of unstable angina (Table 16). Amongst the
survivors, the insulin treated diabetics had a, significantly higher rate
of diabetic complications, including retinopathy (p<.001) peripheral
vascular disease (p<.001) and stroke (p<.05).
Angina amongst the 430 survivors is listed in Table 17. In both
males and females the pattern of return of angina was similar, with
44Vo of patients re-developing angina within 20 months following
surgery. The angina when it returned, was described as: better in
58Vo of patients, the same in 2l7o and worse in 2lVo. Pre-operative
levels of breathlessness were the same in both males and females, but
improved post-operatively in both groups (Figure 57).
'Work levels in surviving diabetic patients at time of review are




MALE FEMALE P VALUE
PRE-EXISTING ANGINA 857o 9lVo P = n.s.
PERIOD FREEOFANGINA 987o 937o p<0.05
RETURN OF ANGINA 38Vo 527o p<0.02
CEREBRO-VASCULAR ACCIDENTS lOVo lSVo p < 0.05
HYPERTENSION 35Vo 6l%o p<0.0001
















Figure 58: Work levels reported in surviving
diabetic patients.
Dyspnoea pre-operatively and post-
operatively in male and female diabetic














5.6 CORONARY ARTERY BYPASS GRAFT COMBINED WITH
ANOTHER CARDIAC PROCEDURE
As experience with coronary artery vein bypass surgery
increased, it was combined with other cardiac procedures. The effect
of adding a coronary artery bypass graft to a valve replacement or an
aneurysm repair both on hospital and long term survival as well as
symptoms was assessed by this study.
Patient Grouo
Between l97l and 1987, 658 patients (82Vo male, l87o female,
mean age 60.4 years, range 31.6-83.1 years) underwent a coronary
artely bypass graft with an additional cardiac procedure. The mean
period of follow-up for the group was 4.5 years with 98.5Vo of patients
successfully located. The total coronary artery experience of the unit
at that time is shown on Table 18 with the associated cardiac
procedure performed. The associated hospital mortality for each
procedure is indicated in Table 19. The annual incidence of combined
procedures is shown in Figure 59 and shows a marked increase
towards the end of the review period.
Operative Details
The time on cardiopulmonary bypass was less than 80 minutes
for 460 patients, with a further 100 between 80-100 minutes. Only
42 patients remained on bypass for greater than L20 minutes. Left
ventricular function was unimpaired in 24Vo of patients, slightly
impaired in 247o, moderately impaired in 387o and severe impairment
was present in l4%o. Similarly, pre-operative X-rays showed no
cardiac enlargement in 437o of patients, mild enlargement in 24Vo,
moderate enlargement in 26Vo and gross enlargement in 7%.
Angiographically assessed ventricular . function was normal in 30Vo of
cases, moderately impaired in líVo, severe impairment in 137o, an area
120
TABLE 18
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Figure 59: Number of cases performed per annum of
coronary artery bypass graft with










Figure 60: Number of grafts inserted at time of




























of single impairment in 35Vo, and multiple areas of impairment in lVo.
A mean of 2.04 grafts were inserted per patient (Figure 60).
Survival
The actuarial survival for the patient group is shown in Figure
6l with no significant difference between the male and female
patients. The cause of death in 198 patients at time of follow-up is
shown on Table 20, with the contributing proportion from the
coronary artery bypass graft and valve patients and coronary artery
bypass graft and ventricular aneurysm surgery. Figure 62 illustrates
the individual survival of the various combined procedures, with no
significant difference between the groups. When survival analysis for
aortic or mitral valve replacements alone was compared with valve
replacement and coronary artery bypass graft, no significant
difference was found, suggesting that the addition of a coronary
artery bypass graft does not increase the risk of the surgery, nor can
it be demonstrated to improve the longterm survival (Figures 63, 64).
A comparison group for aneurysm excision and aneurysm
plication with coronary artery bypass graft and coronary artery
bypass graft surgery is not readily obtainable, but when compared
with patients with moderate or diffuse ventricular contraction
impairment undergoing coronary artery bypass graft alone, no
significant difference was found (Figure 65).
Complications
Haemorrhagic complications (Figure 66) and embolic
complications (Figure 67) requiring hospitalization in survivors,
occurred, depending on the addition of r valve and anticoagulant
therapy given, at a similar incidence to isolated aortic or mitral valve
replacement patients. Of interest was that female patients had a
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Figure 61: Overall survival for male and female
patients following combined procedures.
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Figure 62: Overall survival for patients undergoing

















































Figure 63: Survival in patients with a mitral valve
replacement alone and with associated
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Figure -64: Survival in patients with an aortic valve
replacement alone and with associated
coronary artery bypass surgery.
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Figure 65: Survival for patients undergoing either
ventricular aneurysm excision or
ventricular plication and coronary artery
bypass surgery, compared with patients
undergoing coronary bypass surgery only
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Overall time to embolic complications by
types of additional procedure þerformed
with coronary artery bypass surgery.







hospitalization in males and females
following coronary artery bypass surgery
with another procedure.
Figure 68:
(p<.0001), and for which no apparent explanation exists rt present
(Figure 68).
Symptomatic Outcome
In the 451 survivors, breathlessness was significantly improved
(Figure 69). Activity was "better" in 330 patients (73Vo), the "same" in
75 patients (l1Vo) and "worse" in 46 patients (107o). Angina was
present in 66Vo of patients prior to surgery, but in only 277o at time of
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Figure 69: Breathlessness before and after coronary




























5.7 RESULTS FOLLOWING CORONARY ARTERY ANGIOPLASTY
In order to determine the outcome, complications and need for
subsequent surgery following coronary artery angioplasty, the results
following the first 1155 angioplasties performed in the Royal Adelaide
Hospital Cardiovascular Investigation Unit were determined. It is not
the pu{pose of this study to draw comparisons between andgioplasty
techniques or results, but rather to see how the practice of
angioplasty relates to CABG. A questionnaire was sent to all patients
who had undergone angioplasty (Appendix VII). This quesrionnaire
sought information similar to that already acquired for the coronary
artery patients in the initial follow-up of the first 4,001 patients
(Appendix III). However, the questionnaire was somewhat refined
and shortened in order to gain improved patient compliance. A 977o
complete follow-up was obtained for the patient group. Fourteen
patients had incomplete data and 2l although known to be alive
refused or were unable to reply. No patient had a follow-up of less
than 6 months.
Clinical Results
The immediate clinical angiographic success for the l l55
procedures was 9lVo. The left anterior descendin g 94Vo success in 578
patients, right coronary artery 85vo success in 267 patients, left
circumflex 9o7o in 139 patienrs, 9l% in 155 multiple artery
procedures, IOOVo in two left main coronary arteries and 9l7o in l8
coronary artery bypass graft dilatations. In these procedures the
complication rate was low, there were 3 deaths (O.3Vo), there were 17
myocardial infa¡ctions (1.57o), 18 patients had a CK rise without new e
wave (1.57o), 16 patients had to have an emergency coronary artery
bypass grafting (l.SVo), l7 patients had ventricular fibrillation without
sequelae (1.57o), and 12 had vascular complicarions (l.Ùvo). of the
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original I155 procedures, 127 were repeat percutaneous transcardiac
angioplasties. Of the 1155, the average age \üas 55.9 years and 737o
rwere male. The age ranged from 24 to 79 years.
Mortalitv
Twenty-seven patients have died, 17 had a cardiac cause and l0
had a non cardiac cause. Three died (0.3Vo) within 24 hours of
angioplasty. The total mortality was 2.6Vo. This was 2.2Vo in those
patients who had only one angioplasty and 3.9Vo in those patients who
had two or more angioplasties. Of the 1028 primary procedures, 152
(líVo) had a second procedure. One hundred and twenty seven of
these patients were included in the 1155 procedures. Twenty five
patients had a second angioplasty since the cut off date of the follow-
up, (June 30th, 1988). The study was commenced on the lst January,
1989 giving all patients at least 6 months follow-up. One hundred
and forty (147o) had a coronary artery bypass grafting, at sometime
following angioplasty. Eleven percent of patients who had only I
angioplasty proceeded to coronary artery bypass grafting, whereas
23Vo of 93 patients who had a second angioplasty proceeded to
coronary artery bypass grafting. Sixteen patients had r coronary
artery bypass grafting as an emergency procedure (performed within
24 hours of angioplasty). For ease of analysis the patients are divided
into three groups:
Group A - those who had I angioplasty, no coronary artery bypass
grafting and were alive (899 patients).
Group B - those patients who had 2 or more angioplasties, no
coronary artery bypass grafting and were alive (93
patients).
Group C - those who had coronary artery bypass grafting or had died
(163 patients), were thus excluded from further analysis.
733
On analysis of the arteries (left anterior descending system, left
circumflex system, right coronary system and multiple vessol
dilatations) there were no significant difference between arteries or
multiple vessels as to whether the patient needed r subsequent
angioplasty or coronary bypass grafting.
Myocardial Infarction
Ten percent of patients were re-admitted to hospital at some
time after the angioplasty because of chest pain. This admission was
unrelated to another procedure. If admission was for more than a
few days and myocardial infarction was suspected, details of the
admission confirming myocardial infarction was sought from the
treating doctor. In group A patients this was 3.77o, in group B patients
4.6Vo and in group C those who had surgery or death it was l8%o. Most
of the post-angioplasty myocardial infarction occurred within the first
year. It is not apparent why the high patient percentage which
reported myocardial infarction occurred in those who had surgery.
However, 50vo of those progressing to emergency surgery did have a
limited myocardial infarction.
Anpina
For group A patients, 867o reported having angina before the
first angioplasty, 92Vo had a period free of angina after angioplasty,
but 5l7o said they had recurrence of chest pain at time of follow-up.
They had not sought further intervention for this chest pain. Of those
who had had two angioplasties (group B), glvo had angina before the
first angioplasty, 977o had a period free of angina after the first and
second angioplasty, blt 37Vo had some late recurrent angina. In those
who had surgery (group c), 95vo had angina before angioplasty, 72vo
had a period free of angina after angioplasty, but 93Vo had recurrence
of reported angina before surgery. The severity of the angina was not
134
sought in this study. Most of the angina occurred within the first l0
months following angioplasty (80Vo).
Breathlessness
There !vas an overall increased ability to exercise without
breathlessness following angioplasty. With those who described
breathlessness at rest, it was l37o before angioplasty but only 37o
afterwards. There was also improvement in those who had
breathlessness with light exercise from 23Vo to 97o, similarly with
moderate exercise, with 62Vo of the patients after angioplasty
becoming breathless with strenuous exercise compared with 36Vo
before
Activity
The activity experienced by the patients in general was
improved following angioplasty, 427o in group A and group B said they
could do the same amount of activity, 377o in group A and 4O7o in
group B said they could do more activity, whereas 2l7o in group A and
207o in group B said that they could do less.
Work Participation
As far as could be determined there \ilas no reduction in the
participation in the workforce.
Medication
Fifteen percent of the total group \ilere taking no medications at
time of review, líVo were taking some form of cardiac medication
which could well have been for hypertension, but it was not possible
to determine the precise reason for the medication prescribed.
Twenty-seven percent tvere taking aspirin only, and 34Vo aspirin plus
some other form of cardiac medication. l.6%o describe some form of
complication from the medication (2 had upper gastrointestinal




The precise indications for coronary afiery angioplasty or CABG
remain controversial, however it appears to offer a safe option in
many patients with cardiac chest pain (V/illman, 1984). The
procedure is also apparently cost effective when compared to CABG
(Jang et rl, 1984) and when chest pain is relieved, demonstrates a
high level of return to work with 9O7o still working I.4 years after
angioplasty in a group of patients 60 years or younger (Holmes et al,
1984). When either subsequent or emergency CABG is required in
patients following angioplasty, this appears to be possible without
significant added mortality or morbidity (Akins and Block, 1984;
Foster et al, 1984b; Talley et al, 1989).
This study would support these earlier findings and also
includes the expected early poor results associated with not only the
learning curve of any new procedure, but also the difficulties in
defining patient selection criteria (Kelsey et î1, 1984; Meier and
Grentzig, 1984; Talley et al, 1989).
The occurrence of CABG after the introduction of coronary
artery angioplasty had an initial decrease after the inception of the
technique. In 1978, Gruentzig (Gruentzig et al, 1979) reported that of
their first 50 patients, CABG was performed in 17 (34Vo) within 6
months of the angioplasty. Seven (147o) of these patients requiring
emergency revascularization. Similar results were reported in the
National Heart, Lung and Blood Institute's (NHLBI) registry, which
compiled data from 1977 to 1982 (Detre et rl, 1988). In rhis cohort
the rate of referral for CABG was reduced to a total of 5.67o with only
3.4Vo requiring an emergency operation. This would indicate better
patient selection and more experienced operators. The rate of
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emergency operation compares well with our l.SVo emergency rate,
but subsequent CABG was ll%o. Our overall mortality at about I year
of 2.6Vo, compares with the cumulative reported experience of others
of 3.2Vo (Detre et al, 1989).
Symptomatic outcome following angioplasty in our group of
patients for angina, breathlessness and general activity is comparable
to that reported by others in the NHLBI (Detre et à1, 1988; 1989),
which also showed similar reliance on medications. Overall activity,
angina and breathlessness at one to two years after treatment was not
as favorable as found in CABG patients in either our study (Section
5.1) or by others (CASS, 1983a).
As techniques and experience improve coronary artery
angioplasty will continue to play an increasing role in management of




PROSTTIETIC VALVE REPLACEMENT SURGERY
Despite the ever changing options available in prosthetic valves,
the Cardiothoracic Surgical Unit of the Royal Adelaide Hospital has
tended to follow a conservative approach preferring to use mechanical
valves of the Starr-Edwards or Bjork-Shiley type. While changes in
the details of the valve construction have occurred over the 25 year
review period the basic design of both valves remains fundamentally
unaltered. This study was unable to demonstrate any significant
survival or complication advantage between the various types of
Starr-Edwards or Bjork-Shiley valves used. There was r statistically
significant difference between the incidence of thromboembolic
complications with the aortic Bjork-Shiley valve when compared with
the aortic Starr-Edwards valve over a similar time period however,
the clinical significance of this remains unclear. It is important to
note the difficulties in comparing such complications. In addition,
when performing a large number of statistical tests, occassionally by
chance alone a result will be found to be statistically significant.
Over the period of review both the mitral and aortic surgery has
been associated with a decrease in hospital mortality, which has been
in part due to improved techniques of cardiac surgery and also
improved post-operative care. The actuarial survival observed with
both aortic and mitral surgery highlights the seriousness of tþe
underlying pathology associated with these conditions. Although
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death certificates are a poor substitute for autopsy data, the 6Vo of all
deaths attributed to endocarditis in the mitral valve replacement
group emphasizes the seriousness of this complication. Re-operation
occurring in the mitral Starr-Edwards group was in 4 of the 6 cases
due to endocarditis. The poor outcome associated with patients
suffering from increasing grades of dyspnoea is known, however, it
illustrates the necessity for an early decision to operate before the
condition progresses, with the associated decrease in longterm
survival. The poor outcome in the presence of atrial fibrillation
reflects the increasing liklihood for embolic events in such patients.
Only severe complications in survivors have been assessed. This
avoids collecting retrospective data on deceased patients, however, it
ignores a significant percentage of patients who undergo surgery. By
looking at complications requiring hospitalization the bias of patients
reliably reporting minor complications is removed. Hospitalization
generates the necessary documents to provide evidence of these
complications and also provides an accurate date at which
complications occur, so that actuarial analysis can be performed.
Reports alleging wide superiority of one prosthetic valve type
over another should compare valves inserted contemporaneously,
preferably within the same institution. These studies support the
satisfactory outcome reported with the Starr-Edwards prosthesis in
the mitral position by others (Section II).
Multiple valve replacements carried an hospital mortality of 97o.
However, once discharged from hospital, the longterm survival was
equivalent to the mitral valve replacement group alone.
Until clear changes in valve superiority can be demonstrated,
the Cardiothoracic Surgical Unit, at the Royal Adelaide Hospital is
likely to continue with its use of Starr-Edwards ball caged valves in
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the mitral position and increasingly use the Bjork-Shiley Monostrut
valve for aortic replacements.
PATIENTS UNDERGOING CIORONARY ARTERY BYPASS GRAFT SURGERY
The study of the first 4,001 patients undergoing coronary artery
bypass graft surgery within the Royal Adelaide Hospital, from l97l to
1982, provides a commentary on an evolving operation. The
operation is associated with a low mortality rate, excellent
symptomatic relief, survival for the first 5 years after surgery also
appears to be excellent. Survival data shown in this study beyond
that time cannot be accurately calculated until more patients with
longer follow-up are available. In the period of review the age of
patients, the number of grafts inserted and the proportion of women
undergoing operation has risen. In the same period, hospital
mortality and the duration of cardiopulmonary bypass has fallen.
symptomatic relief has persisted over a prolonged period of time. A
poor symptomatic outcome was usually obvious in the first 12 months
after operation. The rate of second operations is similar to that
reported elsewhere, as is the peri-operative infarction rate.
Although the cost effectiveness of such surgery should be
studied, the operation must first be considered on the basis of
symptomatic relief. This has been established from the results
presented. Others have attempted to demonstrate its effect on
longivity against possible control groups (CAss, 1983a). Ir can be
reasonably deduced that the initial expense of the procedure in the
Australian community is worthwhile in the longterm and may result
in cost savings, although it must be acknowledged that the diagnosis
of heart disease and the subsequent major surgery can precipitate
early retirement from the workforce which appears to occur in about
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4% of the patient group studied.
This study has not been able to clearly identify pre-operative
risk factors that predispose to redo surgery, other than inadequate
bypass grafting at the time of primary operation, or technical errors.
Patients who undergo redo surgery have similar long term survival,
when compared with first-time patients after the hospital mortality is
excluded. The challenge remains to reduce the hospital mortality for
such patients by improved selection and operative techniques. This is
particularly important as about 16%o of patients l0 yeÍus after their
first CABG, will have undergone redo surgery.
The management of diabetic patients requiring coronary artery
bypass graft surgery remains however a difficult problem. These
patients suffer from an increased hospital mortality, which is three
times that of the general patient group. Further, their longterm
survival is significantly shorter than that of the general patient group.
'Whether coronary artery bypass graft surgery has any role to play in
the shortening of the survival of these patients in the longterm is not
clear, nor is it likely to be resolved, as an appropriate control group of
non surgically treated diabetics or medically treated diabetics is not
possible to obtain.
Within the diabetic group the nature of the therapy the patient
receives, be it diet, tablet or insulin may have significant effect on the
longterm outcome for these patients. Female patients controlled by
diet tend to have a higher hospital and longterm mortality when
compared with the tablet and insulin group and this trend is present
also in males. This is despite no major difference between the groups
ît time of surgery. It may be that peri-operative surveillance of diet
control diabetes is not as complete as their insulin controlled
counterparts. After discharge, attending physicians and local doctors
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may not monitor their conditions as closely, when they are not placed
on regular insulin or tablets. If this hypothesis is correct, then it is a
correctable factor.
Further, female diabetics also have a poorer outcome than males
following surgery, with an increased rate of return of angina, higher
stroke rate and higher longterm mortality. The only significantly
different post-operative risk factor between males and females found
in this study, was a higher incidence of women known to be
hypertensive and receiving anti-hypertensive medication. Whether
this finding explains the differences is not certain.
Despite the finding that the insulin dependent group had a
higher rate of complications, such as vascular disease of the eye,
peripheral vessels and cerebral circulation, they did not have an
decreased short or longterm survival. This would suggest that despite
the more aggressive peripheral vascular disease suffered by insulin
dependent diabetic patients, this does not lead to an increased
mortality for these patients following coronary artery surgery.
This study suggests that patients who are diabetic are at
increased risk at time of surgery from coronary artery disease and
that females rre at greater risk than males. Diet controlled diabetics
need to be given greater attention in the peri-operative period
following discharge, as they seem to be a group at increased risk.
Further work is required to define the particular risk factors within
this group.
When patients have a coronary artery bypass graft performed
simultaneously with valve replacement or aneurysm plication, the
addition of the bypass graft does not appear to adversely influence
the long term survival. It is difficult to have adequate control groups
to make useful comparisons in such situations, but the data in this
r42
study would support adding r coronary artery bypass graft, if the
surgeon felt it was clinically indicated on symptomatic grounds.
Coronary artery angioplasty has experienced increasing
popularity, in part because of the ease with which it can be performed
and also the fact that major surgery is not required. The results
presented would indicate that angioplasty can be performed safely in
an experienced centre however, in a situation of repeat angioplasty
patients, there is often a rapid progression to surgical treatment. Only
16 patients required emergency coronary artery bypass grafting as a
result of 1155 angioplasties. Eleven percent of patients having only
an initial angioplasty proceeded to surgery during the period of
review, whereas 237o of 93 patients requiring a subsequent
angioplasty proceeded to coronary artery bypass grafting. It may not
be appropriate for all patients to be subjected to repeat angioplasties,
when it is clear that the disease is unlikely to be controlled for r
prolonged period following angioplastic dilatation.
While the debate still continues as to the need of a cardiac
surgical facility in the institutions performing angioplasty, it is
important to note the low mortality (0.37o) and successful emergency
surgery performed in this group of patients. hether or not similar
results can be obtained where the patient is required to be
transferred to a centre with cardiothoracic surgical facilities is
unknown.
The symptomatic outcome following angioplasty with respect to
activity level, breathlessness and angina, is not as satisfactory as
following coronary artery bypass surgery. However, this must be
offset by not only the lower cost, but also the apparently lesser











2. DIAGNOSIS 1 2 3 4
















Aortlc Tricus AorAn CAD
234s
Aortlc Tricus AorAn CAD
2345























































VSD ASD Fallot PS
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MITRAL 1 2 3
MS MI MS/MI





RAH ACH QEH RGH FMC
NO. OF PREVIOUS CARDIAC OPERATIONS: 1 2
DYSPNOEAOI234









































































































































3l- a ). Shunt R-L
b). Shunt L-R
c). Bl-dlrectlonal Shunt




















































































Explor Palliat Corrct MultiPle
PALLIAT I 2 3 4 5 8
OP Blalck Pott's Clenn Bl-HanPacemaker Other
coRREC. 1 2 3 t¡ 5 6 7 I
Primary ( l) Valvot Valv Valve lnlra Fallot Coarc Aortic Divisn
Plasty Repl card Repair Repair Resect PDA
Sh /Clos
coRREC.r34s67B
Primary (ll) Single LV Double Triple Quad Quin Other
VGraft Resec VGraft VGraft VCraft or +
coRREC.l23{5678
Secon. (l) Vatvot Vatv Valve tntra Fallot Coarc Aortic Divisn
Plasty Repl Card Repair Repair Resect PDA
Sh/Clos
coRREC.l34s678
Secon. (ll) Single LV Double Triple Quad Quin Other
VGraft Resec VGraft VGraft VGraft or +
coRREC.t234s678
Tert. (l) Valvot Valv Valve lntra Fallot Coarc Aortlc Divisn
Plasty Repl Card Repair Repair Resect PDA
coRREC.r345678
Tert- (ll) Single LV Double Triple Quad Quin Other
VCraft Resec VGraft VGraft VGraft or +
CRAFTl23{5
MATERIALS Autogt HomogtHetgt Synth Con¡t¡in
SYNTHET|CST 2 3 q s 6 7 I






35-370 2B-350 < 280
































































































































































I. DATE OF BIRTH
2. SEX: Male = l, Female = 2-








4- INDICATION FOR SURCERY: (Where several indications ex¡st show the two most immedla te )1. Angiographic abnormality rather than symptoms-
2- Angina pectoris, chronic-
3. Unstable angina-
4. Recurring arrhythmia.
5- Acute myocardial infarction-
6. Re-operation for failed revascularisation procedure
7 - Sl¡ortness of Breath.
8- Other.
( Prímary lndication )
(Secondary - if applicable)
OTHER ASSOCIATED DISEASES
5. DIABETES Yes = t. No = Z.
6- CHOLESTEROL Admission vatue mgmt.
7. HYPERTENSION Yes = l, No = 2.
8. OTHER Yes = l, No = 2-




(During the last l2 months)
2,-
27
;0. PREVIOUS OR PRE.,OPERATIVE INFARCT OR INFARCTS
l. No M. l.
2. Single infarct-
3- Multiple infarcts.
¡I. INTERVAL TO LAST PREVIOUS INFARCT:
l- No ínfarct.
2. Up to 24 hours.
3. 2to7days.
4. 8 to l4 days.
5. l5 days to 3 months-
6- More than 3 months.
n 29
30




l. No ischaemic changes.
2. Acute transmural infarct.
3. Chronic transmural infarct-q. Acute subendocardial infarct.
5. Chronic subendocardial infarct.
6- Other myocardial ischaemia (ST - T
wave changes only)











16. L.V. END. DIASTOLIC-PRESSURE mmHg
including a wave if present.





8. L.V- ANCIOCRAM - Contraction-
l. Normal-
2. Contraction impaired - diffuse
3- Contraction impaired - diffuse
q - Contraction impaired - local









r9 L-V- ANCIOCRAM - Aneurysm
l. Anterior.
2 - lnferior- 0
IIT
CORONARY ANCIOCRAM
20. Right main l- Normal.
21. Posterior descend. 2. Narrowed by less than 50å.










4. > 70å or more but less than total.
5. Total obstruction without distal filling























lnferior surf - br-- -
right main
l. Saphenous ve¡n graft end to side.
2. Saphenous vein graft side to side


























lnternal mammary graft (free).







40. OTHER CONCOMITANT PROCEDURES
l. Aneurysm excision -
2. Excision of recent infarct-




7 - VSD closure-
41. DURATION OF BYPASS (minutes)
42 HOSPITAL DISCHARCE _ RESULT.
1. Alive.
2 - Operation table death -
3. 24 hour death-











43" EVIDENCE OF PERI-OPERATIVE INFARCT AT DISCHARCE (determined by new Q wa ves )
l- Yes
2- No.
q4. CAUSE OF DEATH DURINC THIS HOSPITAL ADMISSION
¡. Low cardiac output due to infarct.
2- Arrhythmia due to infarct.
3. Low cardiac output - other causes.



























3. Ventricular Tachycardia -
4. Ventricular Fibrillation within 24 hours post-op
5. Ventricular Fibrillation after first 24 hours-
6. Other.
47. DATE OF DISCHARCE FROM HOSPITAL OR DEATH
IN THE CASE OF RE-OPERATION WAS THIS FOR:
'I - Not Applicable-
2. New Disease-
3. Disease ln Previous Graft.










NUMBER OF PRIOR ANCIOPLASTIES.
l. Date of Angioplasty-















CURRENT GENERÀL PRACIITIONER :
ORRENT CARDTOLOGIST :
l. In which yea¡ did you have your bypass operation? 1,9
ff patienÈ deceased in whlch year? 19
In the questions that follov, Þlease tick the aÞÞroÞr iate boxes to show
which answer ls correct for you.
SYI'lPTOHS :











(21 Have ),ou Ìrad any angina since your oIÞration?
IP YES :











(b) How long after your operation did the angina first
reappear? {ln months, e.g. for 23 months)
I
l3) Did you have shortness of breath before vour operation?
YES
NO











(a) Compared with the shortness of breath before your
operation is it :







What was the date
For what reason
Was a further bypass operation necessary? vDs
NO
3 ACTIVITY:
Please compare your level of activity and exerc.ise before arrd after
the operatlon.




Ploase tick one box in each column :




did shorÈness of breaÈh
23 nonths)
(b) How long after your operation





































If a housewife and not otherwise ernployed were you able to do :

























Conanunlty attltudes to your heart disease
Poor job opportunities

























(f) Please list all- drugs you are currently taking
9lruld you specify any of the above drugs that you at.e takinc
for high blood pressure :
154
pqge 4
















(l) Dld you smoke before your operati-on? YES
NO
(a) Do you s¡noke now? 3 NO
YES BUT I,ESS TIUTN BEFORE
r-ES THE SÀHE ÀS BEFORT
\ES }IORE TITAN BEFORE
Thank you for your help.
I'Iease check that you have answered all the questions then rer:urn thLs
form in the reply-paldt envelope provl.ded. to:
Cororary Àrtery Sunrey Secretâry,













The Cardio-Thoracic Surgical Unit of the Royal Adelaide
HospitaJ- is embarking' on a major follow-up study of aII
patients who have undergone coronary artery grafting in this
unit. The survey up to the end of L981 embraces over 41000
patients and is the larqest in Australasia. ft is obviousty
of vital- interest to know the long term results of the
operation and vre therefore seek your co-operation in filling
out the attached questionnnaire, and returning it in the reply
paid envelope encl-osed.
The co-ordinator of this survey is Dr. Guy Maddern and any
enquiries can be directed to him by ringing the Royal Adelaide
Hospital during office hours.





NOTE: If, for some reason, the patient is unable to complete
the questionnaire or is deceased, could the nearest relative
please do so to the best of their ability, and write on the










PLEASE FILL THE APPROPRIATE BOX:
l. In which year did you have your walve replacemenc operacion? 19DL]
2. If patienc is deceased:
l) What ç¡as Èhe dare of death - e.g. lsÈ June 1973
(If date unknown, give year)
2) In which Scate of Auscralia?




3. We arc lncerested in assesslng your Ìeve1 of breathlessness
before and afÈer operaÈÍon. please nark ONE box in each
colu¡rn appropriåte Eo your condlcion inneãlãteLy prior Èo




opera t io n
l) Breachless only on very sÈrenuous exercise
2) Breachless with moderately sÈrenuous acÈfviCy
only e,g., housework, valking sport etc.
3) Breachless wich lighÈ activiry, e.g. showering,
dressing, walkÍng on che f1at.
4) Breathless even aÈ resÈ



























5. Have you in Èhe pasÈ, or ere you currently taklng antfcoagulant
ÈableEs (blood Èhinning cablets). because of your valve?
NO
YES
If YES (thac is, if you are on anticoagulants) have you
had any bleeding as a resuÌÈt
YES bur noE requiring hospitallza!ion .
YES requiring hospicalizaÈion
Which hospical? Doctor Year










YES buc noÈ requirlng hospitalfzation .
YES requiring hosplcallzatÍon .....
Which hospltal? DocEor Year
Type of clot problem
7- Have you required hospicalizacion for any oÈher reasons due to your























OIAEETIC CORONARY BYPASS QUESTIOXNAIRE
Seq. No.
UR No.












(a ) If patient deceased couìd you pìease state date and
cause of death.
(b) Have you had another coronary bypass?











lle are also interested in your chest pain on exertion
before and after coronary bypass.







c) Has the ¿n
d) If so, how
the angina
YES /NO
YES /NOg i na
I ong
come
come back since your bypass?
after the first bypass did
(e) If the angina has returned, compared with angìna prior




3. Have you had a "heart attack" since coronary bypass? yES/NO
I f so, when
back?
.,
l,lhich hospitaì did you attend 2
PLEASE TURN OVER
159
4 l,le are i nterested
breathìess before
i n assessi ng
your þypas s
what it takes to
and now.
Be fo re





















s i ca I
, etc.,
(b ) Breathl ess wi th moderateìy
strenuous actìvity e.g.
housework, waìking, sport.
(c) Breathìess with ìi9ht activity
e.g. showering, dressing,







Si nce bypass wouì d you regard







long hðve you h¿d diabetes?
ì ess
s ame




(b) llhat is your current
DIET onìy
DIET E TABLETS
Pì ease gi ve name
No. taken daiìy?











DIET & INSULIN YES
Please give nðme of insuìi
No. of i nj ect i ons per day?





you have high bìood pressure(






you had any compì i cat i ons as a resuì t
Eye probl ems needi ng ì aser therapy?
Kidney probìems?
Bìood vessel disease in the ìegs?












Do you perform any bìood tests at home? YES/NO





CORONARY ANGIOPLASTY FOLLOW-UP OUESTIONNAIRE
Seq. No.
UR No.Addres s
Telephone: Date of Blrth
PLEASÐ ANSI,JER THE FOLLOI.IINC QUESTIONS
day nonth year
'1. Date of Flrst Coronary Angloplasty?
(tr you reuenber)
a) Have you bad auotber Coronary Anglopl as ty?
If so, when?
If so, uhere?
b) Havo you had a heart operatlon slnce angloptasty?




2 We are aLso lnterested 1n your chost paln on exertlon (anglna)
bofore and alte¡ coroDary angioplasty.
a) Otd you have angina beforo your flrst angioplasty? yes /
b) After angloplasty, did you have a period free of angina? yes /
c) Has the anglna cone back slnce your angloplasty? yes /











hosplta). d1d you attend?
We are lnterested 1D assesslng r¡hat 1t takes to nake you
breathlessness before and after angloplasty. please place
ONE tlck 1n the approprlato colunn to descrlbe your condltlon
lnnedlateLy b€fore your flrst auglopLasty and to desc¡lbe
your preseat condltlon. Before
flrs t
a) Breathless oa very strenuous exerc1se,e.g,
runnlng, or cIlnblng rnore tban 3 fllgbts of
stalrs.
angloplas ty
b) Breathless r¿lth noderately stretruous actlvlty
onIy, e.g. housevork, valklng, sport, etc.
c) Breathless vlth l1ght actlvlty, e.g, sbowerlag,
dresslng, valklug oa the flat.






5 . l.Jhat Eedlcatlon and tabl.e ts are you currently taklng?
Have you bad any coapllcatloDs frorl your !¡edlcatloD?
If so, what a¡e the conplicatlons?
Yes / No
Have you needed to be adnltted to bospltal for any roason
slDce your anglopJ.asty, e.g. lnfectlon, chest paln, operatlon,
Ior¡ blood count, eic .? yes ,/ No
If yes, please state reason:
l.lhlch hospital?
tlhen?
l.le are lnterested la your ablllty to vork before aud after
coroDary angloplasty. (Pleaso ü1ck the approprlate box,)
a) lJere you vorki-ng 1n fuJ.l-t1ne or part-t1no Full-tlne
pald eroploynent before your flrst angloplasty part-tlne
Not uorklng
b) FotlovlDg your
enp Ioyneu t ?
If so, vere you









vould you regard your abillty to do





8. Do you have any co!3etrts about
- the survey
- co¡oDary angloplasty
- your experieDce at RoyaL Adelalde Hospltat
- aDy other connents?
7
Yes,/ No








CÀRDIO-THORÀCTC SURGTCAL UNIT FINANCE DTVTSION
CÀRDIO-IHORÀCIC SURGICÀL I'NIT
BY-PÀSS STI]DY
Part of this study is to ascertain the cost of performing a lHeart
By-pass Operationr. Certain costs associated with the operation are
directly related to this type of operation, e.9. the level of Nursing and
Medical- Care, Medical and Surgical Supplies and several other costs for
the operation- Several direct cosÈs are available from Èhe Cost Centre
Reports for CTSU, the two Wards and the Cardio-Thoracic Theatre.
The additional cost to be determined is a bed cost for general
overheads, e.g. FueI, Cleaning, Àdministration, Maintenance etc. The
derived rCost per Occupied Bed Day' for 1981-/82 is 9215.43. This
however, is not the cost reguired for this exercise as it is an average
cost for a rHospital Bedt,' not an À4 or À5 bed- The basis of calculation
is si¡nil.ar and is used to deternr-ine an tadd-on notional valuet for a
Hospital Bed, additionaL to certain treatment costs for a By-Pass
Patient, (i.e. Medical, Nursing and Scientific e Technical Salaries,
Pathology, Radiolog'y, Durgs, Medical & Surgical Supplies etc.).
À cost of $85.45 per occupied bed day has been calculated and should
be regarded as a proportion of INPATIENT COSTS for L98L/82. Additional
direct costs, including those on the Cost Centre Reports should be taken
into account-
PhiI Southam














Of Salaries; Medical, Nursing, Scientific & Technical and some
Àdnr-inistration are directly debited Èo the Cardio-Thoracic Cost Centres-
Therefore, total Medical-, Nursing and direct Scientific & Technical and.
Administration salarieg should be deducted from 'overhead. salaries-
Less -Nursing ç2L,456r354-32
- Medical 10,357,163-16

















4 , 055, 31 1-32
8,066,75L-46
- Food Supplies
- Medical & Surgical
- Fuel, Light & Porrer
- Domestic Supplies
- Àdditional Works & Serv.
- Equipment
- Maintenance Contracts
- Repairs & Maintenance
- Admin. Expenses
- Pathology Charges
s 27 , 019,2'16-72
Deduct from rtoverheads"; Medical & Surgicat Supplies, Equipment (Direct
Debit), Maintenance Contracts and Patholog-y Charges-
TOTAL'OVERHEÀD" GOODS E SERV. 10,071,450-34











- Fuel, Ltght & power




- Fuel, Light & Por.rer
- Domestic Supplies
- Group Laundry & C.L.S.





























DERTVÀTION OF NON-INPATIENT COSTS
- Salaries & Wages S 2L,953,41?-01
less Conununicable Dis. 332,308-48
Catering Sala¡ies 2r877,9L2-27
s 18,753tL96-26
Non-Inpatient (Based on occasions of service)








Non-Inpatient (Based on occasions of service)
-222624 x S7, 441,455-40
- Total Goods & Services
Iess Dental
Conrnunicable Dis.













NON-INPÀTIENT GOODS & SERV"
DENTAL
COMMUNICABLE DISEASES
.OVERHEÀD' INPATIENT G C S
CALCULÀTTON OF 'NOTIONAL ADD-ON VALUE'
Inpatient "overhead" Salaries
Inpatient "overhead' Goods & Services
Less Meals & Accomodation (Staff)
Occupied Bed Days : 29L,722







* To be added to costs of Nursing Salaries, Me¿ìical Salaries, Scientific
& Technical Salaries (CTSU Theatre), DirecÈ Administrative Salaries,
Radiolog¡¡ & Pathology Charges, Equipment Purchases, Medical & Surgical





L/7 /8L - 30/6/82





























































Pat Mon Equip Card Thoracic
Pacemakers Cardio TH OP TH
Catheters Card Thoracic
Trans & Infusion C Thoracic
Needles Card-Thoracic
Àppl e fnst Card Thoracic
Spec fnst Card Thoracic
Spec Surg Inst Card thorac
Dres Band Plaster C thorac
Surg Dres & Band C Thorac
Sutures C Thorac
IÈems-Home Dial C Thorac
Prostheses C Thorac
Spec ImpI Pros C Thorac
fmpl Heart Valves C Thorac
Àrterial Grafts C Thorac
MedúSurgSup- CThorac
Med É Surg fmpr C Thorac
Face Masks Paper C Thorac
Protect Gar Disp C Thorac
Tubes&Access CThorac
Gloves Surgeon C Thorac
Disp Gloves C Thorac
Drainage Bags C Thorac
Sterilizing fndi C Thorac
By-Pass Eguip C Thorac
Disp Oxygenators C Thorac
Film Tubing C thorac
Àutoclave Bags C Thorac
Autocl-ave Paper C Thorac
Drainagre Equip C Thorac
Other C Thorac
CAT Scanner Fees C Thorac











































22802 6050 Footwear C Thorac
28210 6050 Repl Eguip Med C Thorac
28260 Rep Other C Thorac
29260 6050 Àdd Eguip Other C Thorac
31210 6050 Rep - Equip Med C Thorac






























Med & Surg Impr
Tubes & Àccess















































282L0 6342 Repl Eguip Med




Repl L Prop A4
Staff Staff À4
TOTAL FOR COST CENTRE
168
-6-


















Med & Surg Impr


























25230 6352 Other Works À5 2097.04
29260 6352 Àdd Eguip oth A5 3s-66
34561 6352 Taxi Staff -A5 Card Vasc 10.57
TOTÀL FOR COST CENTRE 277537.53
169
-7-

































4 05256 - 9s













292L0 7352 Add Eguip Med Cardio Th 4404.00
3L220 7352 Rep - Eguip Oth Cardio Th 73.46
Needle Disp Cardio Th
SPec Surg,Inst Cardio Th
Iì{t¡S Path - rnpat Cardio Th
CoÍtputer Services Cardio Th
Data Processing Cardio Th
Taxi Staff Cardj o Th
TOTÀL FOR COSI CENTRE
170
BIBLIOGRAPHY
Akins CV/, Block PC. Surgical Intervention for failed Percutaneous
Transluminal Coronary Angioplasty. Am J Cardíol 1984; 53:
108-r 1.
Alderman EL, Fisher LD, Litwin P et al. Results of coronary artery
surgery in patients with poor left ventricular function (CASS).
Circulatíon 1983; 68 (4): 785-95.
Anderson AJ, Barboriak JJ, Hoffman RG et al. Retention or resumption
of employment after aortocoronary bypass operations. Am Med
Assoc J 1980; 243: 543-5.
Anderson RP, Bonchek LI, V/ood J et al. The safety of combined aortic
valve replacement and coronary bypass grafting. Ann Thorac
Surg 19731' 15: 249-55.
Angel WW, Shumway NE Kusek JC. A five year study of variable
aortic valve homografts. J Thorac Cardíovasc Surg 1972:. 64:
329 -39 .
Aris A, Fast AJ, Tector AJ et al. A comparative study of ball and disc
prostheses in mitral valve replacement. J Thorac Cardíovasc
Surg 19741'68: 335-43.
Arnett EN, Roberts V/C. Prosthetic valve endocarditis:
Clinicopathologic analysis of 22 necropsy patients with
comparison of observations in 74 necropsy patients with active
777
infective endocarditis involving natural left-sided cardiac valves.
Am I Cardiol 1976; 38 (3): 281-92.
Assad-Morrell JL, Fry RL, Connolly DC et al. Aorta-coronafy aftery
saphenous vein bypass surgery: Clinical and angiographic
results. Mayo CIín Proc 1975;50 (7): 379-86.
Aurelio C, Czer LSC, Matloff JM. The St. Jude Medical bileaflet valve
prosthesis : a 5 year experience. J Thorac Cardíovasc Surg 1984;
88: 706-17.
Australian Bureau of Statistics. 1981 Life tables for South Australian
Bureau of Statistics. The labour force, Australia Thompson,
Commonwealth Government Printer, Canberra 1982; Catalogue
number 6203 0 CJ.
Barnes GK, Ray MJ, Oberman A et al. Changes in working status of




aortic valve replacement in aortic
Thorax 1964; l9: 131-50.
Beall AC, Jr, Bloodwell RD, Liotta D et al. Clinical experience with a
dacron velour-covered teflon-disc mitral-valve prosthesis. Ann
Thorac Surg 1968; 5: 402-lO.
Bjork VO. A new tilting disc valve prosthesis. Scand J Thorac
Cardiovasc Surg 1969;3: 1-10.
172
Bjork VO. Experience with the Wada-Cutter valve prosthesis in the
aortic area: One year follow-up. J Thorac Cardiovasc Surg 1970;
60:26-33.
Bjork VO, Olin O. A hydrodynamic evaluation of the new tilting disc
valve (Bjork-Shiley) for mitral valve replacement. Scand J
Thorac Cardíovasc Surg l97O; 4:37-43.
Bjork VO, Henze A, Holmgren A. Central haemodynamics at rest and
during exercise before and after operation with the Bjork-Shiley
tilting disc valve in patients with aortic stenosis. Scand f Thorac
Cardtovasc Surg 1973; 7: lll-30.
Bjork VO. Metallergic and design developement in response to
mechanical dysfunction of Bjork-Shiley heart valves. Scand J
Thorac Cardiovasc Surg 1985; 19: l-12.
Bjork VO. The Bjork-Shiley tilting disc valve: past present and future.
Cardiac Surg 1987; l: 183-202.
Bloodwell RD, Okies JE, Hallman GL et al. Aortic valve replacement:
Longterm results. J Thorac Cardiovasc Surg 1969; 58: 457-66.
BMDP statistical software (1981 version) Los Angeles University of
California at Los Angeles 1981.
Bonchek LI, Starr A. Ball valve prostheses. Current appraisal of late
results. Am J Cardiol 1975; 35: 843-54.
773
Boncheck LI. Current status of cardiac valve replacement: Selection of
a prosthesis and indications of operation. Am Heart ,I 1981; 101
(1): 96--106.
Bourassa MG, Enjalbert M, Campeau L et al. Progression of
Atherosclerosis in Coronary Arteries and Bypass Grafts: Ten
years later. Am J Cardíol 1984; 53: lO2-7.
Braunwald NS, Boncheck LI. Prevention of thrombus formation on
rigid prosthetic heart valves by the ingrowth of autogenous
tissue. f Thorac Cardiovasc Surg 1967; 54: ó30-8.
Brett AS.
Med
Ethical issues in risk factor intervention. (Edítorial) Am J
1984; 76 @): 557-6r.
Brooks N, Cattell M, Jennings K et al. Isolated disease of left anterior
descending coronary artery: Angiocardiographic and clinical
study of 218 patients. Br H.eart J 1982; 47 (l): 7l-7.
Brower RW, Laird-Meeter K, Serruys PV/ et al. Longterm follow-up
after coronary artery bypass graft surgery: Progression and
regression of disease in native coronary circulation and bypass
grafts. Br Heart J 1983; 50 (1): 42-7.
Buda AJ, MacDonald IL, Anderson MJ et al. Longterm results
following coronary bypass operation. Importance of pre-
operative factors and complete revascularization. I Thorac
Cardiovasc Surg 1981; 82 (3): 383-90.
174
Califf RM, Tomabechi Y, Lee KL et al. Outcome in one vessel coronary
artery disease. Circulation t983; 67 (2): 283-90.
Campeau L, Enjalbert M, Lesperance J et al. Atherosclerosis and late
closure of aortocoronary saphenous vein grafts: sequential
angiographic studies at 2 weeks, I year, 5 to 7 years, and 10 to
12 years after surgery. Círculation 1983; 68 (3 Pt 2): II l-7.
Cannell CF, Marquis KH, Laurent A.
interviewing methodology. Vital
publication no. 1,000 Series 2 no. 69.
A summary of studies of
and Health Statistícs PHS
Washington DC: GPO, 1977.
Carpentier A, Blondeau P, Laurens B et al. Mitral and Tricuspid valve
replacement with frame mounted aortic heterografts. J Thorac
Cardiovasc Surg 1968; 56: 388-94.
Carpentier A, Lenaigre G, Robert L et al" Biological factors affecting
long-term results of valvular heterografts. J Thorac Cardiovasc
Surg 1969; 58; 467-83.
CASS - Coronary Artery Surgery Study. A




CASS principal investigators and their associates - Coronary artery
surgery study (CASS): A randomized trial of coronary artery
bypass surgery. Quality of life in patients randomly assigned to
treatment groups. Circulstíon 1983b; 68: 951-60.
175
Castelli V/P. Epidemiology of




Chaffin JS, Daggett WM. Mitral valve replacement: a nine year follow-
up of risks and survivals. Ann Thorac Surg 1979; 27 (4): 312-9.
Chait LO. Use of select mortality tables to re-evaluate CABG.
Circulation 1982; 65: 1286.
Charuzi Y, Beeder C, Marshall LA et al. Improvement in regional and
global left ventricular function after intracoronary thrombolysis:
Assessment with two-dimensional echocardiography. Am J
Cardiol 1984;53 (6): 662-5.
Christian CB, Mack J'W, Wetstein L. Current status of Coronary aÍery
bypass grafting for coronary artery atheroslerosis. Surg Clínc
Nth Am 1985; 65 (3): 509-26.
Christakis GT, Kormus RL, Weisel RD et al. Morbidity and mortality in
mitral valve surgery. Circulation 1985; 75: 120-8.
Cobanoglu A, Freimanis I, Grunkemeier G et al. Enhanced late
survival following coronary artery bypass graft operation for
unstable versus chronic angina. Ann Thorac Surg 1984; 37 (l):
52-9.
Codd JE, Wiens RD, Kaiser GC et al. Late sequelae of peri-operative
myocardial infarction. Ann Thorac Surg 1978; 26 (3): 208-14.
176
Cohn PF, Harris P, Barry WH et al. Prognostic significance of anginal
symptoms in angiographically defined coronary artery disease.
Am J Cardiol 1981; a7 Q): 233-7.
Cohn PF. Prognosis and treatment of asymptomatic coronary artery
disease. J Am Coll Cardiol 1983a; 1 (3): 959-64.
Cohn PF, Brown EJ, Wynne J et al. Global and regional left ventricular
ejection fraction abnormalities during exercise in patients with
silent myocardial ischemia. J Am Coll Cardiol 1983b; I (3): 931-
3.
Cohn LH, Allned EN, Di Sesa VJ et al. Early and late risk of aortic valve
replacement. A 12 year concomitant comparison of the porcine
bioprosthetic and tilting disc prosthetic aortic valves. J Thorac
Cardiovasc Surg 1984; 88: 695-705.
Connors JP, Thanavaro S, Shaw RC et al. Urgent myocardial
revascularization for dissection of the left main coronary artery:
A complication of coronary angiography. J Thorac Cardiovasc
Surg 1982; 84: 349-52.
Copeland JG, Griepp RB, Stinson EB et al.




Corday E, Corday SR. Arteriosclerosis remains r dilemma. Int J
Cardiol 1983; a Q): 216-20.
177
Cosgrove DM, Loop FD, Saunders CL et al. Should coronary arteries
with less than fifty percent stenosis be bypassed? J Thorac
Cardiovasc Surg 1981; 82: 52O-30.
Cosgrove DM, Loop FD, Sheldon WC.




Cosgrove DM, Loop FD, Lytle BW et al. Predictors of re-operation after
myocardial revascularization. J Thorac Cardíovasc Surg 1986; 92:
8tt-21.
Craddock DR, Nunn GR, Sutherland HD et al. Coronary artery surgery
in South Australia 1970-1976. Med I Aust 1977; 2 (17): 553-7.
Craddock DR, Ross IK, Stubberfield J et al. Coronary artery surgery in
South Australia: second report. Med I Aust 1980; l: 491-3.
Cross FS, Jones RD. A caged-lens prosthesis for replacement of the
aortic and mitral valves. Ann Thorac Surg 1966; 2: 499-507.
Culliford A, Girdwood R, Isom W et al. Angina following myocardial
revascularization. Does time of recurrence predict etiology and
influence results of operation? I Thorac Cardiovasc Surg 1979;
77:889-95.
Czer LSC, Gray RJ, DeRobertis MA et al. Mitral valve replacement:
impact of coronary artery disease and determinants of prognosis
after revascularization. Circulation 1984; 70 (Suppl I): I 198-
178
207 .
Dale J, Myhre E, storstein o et al. Prevention of arterial
thromboembolism with acetylsalicylic acid: A controlled clinical
study in patients with aortic ball valves. Am Heart J 1977; 94
(1):101-11.
Dale J, Levany O, Enge I. Longterm results after aortic




Dale J, Myhre E. Can acetylsalicylic acid alone prevent arterial
thromboembolism? A pilot study in patients with aortic ball
valve prostheses. Acta Med Scand l98l; 645 (Suppl): 73-8.
Detre K, Holubkov R, Kelsey S et al. Percutaneous transluminal
coronary angiolpasty in 1985-86 and 1977-81. The National
Heart, Lung and Blood Institute Registry. N Eng J Med 1988;
265-70.
Detre K, Holubkov R, Kelsey S et al. one year follow-up results of the
1985-86 National Heart, Lung and Blood Institutes Percutaneous
Transluminal Coronary Angioplasty Registry. Circulation 1989;
80: 421-8.
Devineni R, McKenzie FM. Surgery for coronary artery disease in
patients with diabetes mellitus. can J surg 1985; zB (4): 367-
70.
179
DiSesa VJ, Cohn LH, Collins JJ et al. Determinants of operative survival
following combined mitral valve replacement and coronary
revascularization. Ann Thorac Surg 1982' 3a 6): 482-9.
Dismukes wE, Karchmer AW, Buckley MJ et al. Prosthetic valve
endocarditis. Analysis of 38 cases. circulation 1973; 48: 365-
77.
Douglas PS, Hirshfeld fW, Edie RN et al.
and porcine aortic valve prosthesis.
9.
Duncan JM, Cooley DA, Livesay JJ et al.
Early clinical results in 253 patients.
10: 1 1-6.
Clinical comparison of St. Jude
Circulation 1985; 72: 135-
The St. Jude Medical valve.
Texas Heart In$ f 1983;
Duran CG, Gunning AJ. A method for placing a total homologous aortic
valve in the subcorona¡y position. Lancet 1962; 2: 488-9.
ECCS - European Coronary Surgery Study Group. Longterm results of
prospective randomised study of coronary artery bypass
surgery in stable angina pectoris. Lancet 1982; 2: 1173-80.
Favaloro RG, Effler DB, Groves LK et al. Severe segmental obstruction
of the left main coronary artery and its divisions. Surgical
treatment by the saphenous vein graft technique. J Thorac
Cardiovasc Surg l97O; 6O: 469-82.
180
Fitzgibbon GM, Leach AJ, Keon wJ et al. coronary bypass graft fate:
Angiographic study of ll79 vein grafts early, one year and five
years after operation. ./r rhorac cardíovasc surg 1986; 9l: 773-
8.
Foreman R, Firth BG, Barnard MS. Prognostic significance of pre-
operative left ventricular ejection fraction and valve lesion in
patients with aortic valve replacement. Am J cardíol 1980; 45:
tt20-5.
Forssman V/TO. Die sondierung des rechten herzens. Ktin Wochenschr
1929; 8: 2085-7.
Foster ED, Fisher LD, Kaiser GC et al. Comparison of operative mortality
and morbidity for initial and repeat coronary artery bypass
grafting: The coronary Arrery surgery study (cASS) Registry
experience. Ann Thorac Surg L984a;38: 563-70.
Foster ED, Fisher LD, Kaiser GC et al. potential for percutaneous
Transluminal Coronary angioplasty before Initial and Repeat
coronafy artery bypass grafting in the coronary artery surgery
study (CASS) Registry Population. Am J cardiol 1984b; 53: ll2-
5.
Frey RR, Bruschke AVG, Vermeulen FE. Serial angiographic evaluation
I year and 9 years after aorta-coronary bypass. A study of 55
patients chosen at random. .r rhorac cardiovasc surg l9B4; 87
(2): 167 -74.
181
Ganz 'W, Geft I, Shah PK et al.
acute myocardial infarction.
Intravenous streptokinase in evolving
Am I Cardiol 1984; 53: 1209-16.
Gibbon JH. Application of a mechanical heart and lung apparatus to
cardiac surgery. Mínn Med 1954; 37: 171-85.
Gordis L. Assuring the quality of questionnaire data in epidemiologic
research. Am J Epidemiol 1979; 109: 2l-4.
Gordon T, Kannell V/B. Premature mortality from coronary heart
disease: The Framingham study. JAMA l97l; 215: 1617-25.
Gruentzig AR, Senning A, Siegenthaler V/E. Nonoperative dilation of
coronary artery stenosis. Percutaneous transluminal coronary
angioplasty. N Eng J Med 1979; 301: 6l-8.
Haft JI, Bachik M. Progression of coronary artery disease in patients
with chest pain and normal or intraluminal disease on
arteriography. Am Heart J 1984; 107 (l): 35-9.
Hall RJ, Elayda MA, Gray AG et al. Coronary artery bypass: Longterm
follow-up of 22,284 consecutive patients. Circulation 1983; 68:
tt20-6.
Hall RJ, Elayda MA, Gray AG et al. Re-operation for coronary artery
disease. J Am Coll Cardíol 1986; 7: 32A (abstract).
Hammermeister KE, De Roven TA, English MT et al.




coronary artery disease. Am I Cardiol 1979a; aa 0): 105-11.
Hammermeister KE, De Roven TA, Dodge HT.
randomized study that coronary surgery
patients with two vessel coronary disease.
59 (3): 430-5.
Harken DE, Taylor WJ, Lefemine AA et al.
with a caged ball valve. Am J Cardiol





Harford CJ. Post-operative fungal endocarditis. Fungemia, embolism
and therapy. Arch Intern Med 1974; 134 116-20.
Harken DE, Soroff HS, Taylor WJ et al. Partial and complete prostheses
in aortic insufficiency. J Thorac cardiovasc surg 1960; 40: 744-
62.
Harris PJ, Harrell FE Jr., Lee KL et al. Survival in medically treated
coronary artery disease. Circulation 1979; 60 (6): 1259-69.
Harris PJ, Harrell FE Jr., Lee KL et al. Outcome in medically treated
coronary artery disease. Ischemic events: nonfatal infarction
and death. Circulation 1980; 62 (g: 718-26.
Herr RH, Starr A, Pierie WR et al. Aortic valve replacement: a review
of six years experience with the ball valve prosthesis. A n n
Thorac Surg 1968; 6: 199-218.
I83
Hochstim JA. A critical comparison of three strategies of collecting
data from households. J Am Statist Assoc 1967; 62: 976-89.
Hodam R, Anderson R, Starr A et al. Further




Holmes DR, VanRaden MJ, Reeder GS. Return to work after Coronary
Angioplasty: A Report from the National Heart, Lung and Blood
Institute Percutaneous Transluminal Coronary Angioplasty
Registry. Am J Cardiol 19841' 53: 48-51.
Horstkotto D, Konder R, Seipel L et al. Late complications in patients
with Bjork Shiley and St. Jude Medical heart valve replacement.
Circulation 1983; 68 (2): 175-84.
Hufnagel CA, Harvey WP. The surgical correction of aortic
regurgitation. Preliminary Report. Bull Georgetown U Med Ctr
1953;6: 60.
Hufnagel CA, Harvey WP, Rabil PJ et al. Surgical correction of aortic
insufficiency. Surgery 1954; 35: 673-83.
Hufnagel CA, Conrad PlV. Comparative study of some prosthetic
valves for aortic and mitral replacement. Surgery 1965; 57:
205 -to .
Ionescu MJ, Wooler GH, Smith DR et al. Mitral Valve replacement with
aortic heterografts in humans. Thorax 1967; 22: 3O5-13.
184
Ionescu MI, Ross DN. Heart-valve replacement with autologous fascia
lata. Lancet 1969; 2: 335-8.
Ionescu MI, Pakrashi BC, Holden MP et al. Results of aortic valve
replacement with frame-supported fascia lata and pericardial
grafts. J Thorac Cardiovasc Surg 1972; 64: 340-53-
Isom OW, Williams CD, Falk EA et al.
covered metallic ball prostheses.
1972; 64: 354-67.
Longterm evaluation of cloth-
I Thorac Cardiovasc Surg
Jacobs ML, Fowler BN, Vezeridis MP et al. Aortic valve replacement:
A nine year experience. Ann Thorac Surg 1980; 30 (5): 439-47.
Jang GC, Block PC, Cowley MJ et al. Relative cost of Coronary
Angioplasty and Bypass Surgery in a one-vessel disease model.
Am J Cardiol 1984; 53: 52-5.
Johnson DW, Hoffman J, Flemma R et al. Seconda¡y surgical procedure
for myocardial revascularization. I Thorac Cardiovasc Surg
1972;64:523-9.
Johnson DW, Kayser KL, Pedraza PM et al. Employment patterns in
males before and after myocardial revascularization surgery. A
study of 2229 consecutive male patients followed for as long as
l0 years. Circulation 1982a; 65: 1086-93.
Johnson DW, Pedraza PM, Kayser KL. Coronary artery surgery in
diabetics: 261 consecutive patients followed four to seven years.
185
Am Heart f ß82b; lO4: 823-7.
Jones EL, Craver JM, King SB et al. Clinical anatomic and functional
descriptors influencing morbidity, survival, and adequacy of
revascularization following coronary bypass. Ann Surg l9g0;
r92 (3): 390-402.
Karchmer Aw, Dismukes 'wE, Buckley MJ et al. Late prosthetic valve
endocarditis: Clinical features influencing therapy. Am J Med
1978; 64 (Z): 199-206.
Kay JH, Kawashima Y, Kagawa y et al. Experimental mitral valve
replacement with a new disc valve. Ann Thorac surg 1966a; 2:
485-98.
Kay EB, suzuki A, Demaney M et al. comparison of ball and disc
valves for mitral valve replacement. Am J cardiol 1966b; 1g:
504-14"
Kay PH, Nunley D, Grunkemeier GL et al. coronary bypass as a risk
factor in aortic valve replacement: A multivariate analysis at ten
years. JACC 1984; 3: 6M.
Kelsey SF, Mullin SM, DeFe KM et al. Effect of Investigator Experience
on Percutaneous Transluminal coronary Angioplasty. Am J
Cardiol 1984; 53: 56-64.
Kennedy IW, Kaiser GC, Fisher LD et al. Multivariate discriminant





f Thorac Cardiovasc Surg
in coronary artery
1980; 80 (6): 876-87.
Kerwin A, Lenkel SC, V/ilson DR. Aortic-valve homograft in the
treatment of aortic insufficiency: Report of nine cases, with one
followed for six years. N Eng J Med 1962; 266: 852-7.
Kircher T, Nelson J, Burdo H. The autopsy as a measure of accuracy of
the death certificate. ¡f Eng J Med 1985; 313: 1263-9.
Kouchoukos NT, Oberman A, Kirklin JW et al. Coronary bypass
surgery: analysis of factors affecting hospital mortality.
Circulation 1980; 62 (2 Pt 2): 184-9.
Kramer JR, Kitazume H, Proudfit WL et al. Progression and regression
of coronary atherosclerosis: Relation to risk factors. Am Heart J
1983; 105 (1): 134-44.
Laird-Meeter K, Katen HJ, Brower RW et al. Angina pectoris one to ten
years after aorto-coronary bypass surgery. Eur Heart f 1983; 4
(10): 678-86.
Lawrie GM, Morris GC, Glaeser DH. Influence of diabetes mellitus on
the results of coronary bypass surgery. Follow-up of 212
diabetic patients ten to fifteen years after surgery. JAMA 1986;
256: 2967 -71.
Lepley D, Flemma RJ, Mullen DC et al. Late evaluation of patients
undergoing valve replacement with the Bjork-Shiley prosthesis.
r87
Ann Thorac Surg 1977;2a Q): l3l-9.
Lillehei C'w, Kaster RL, Coleman M et al. Heart valve replacemen!
with Lillehei-Kaster pivoting disc prosthesis. I'lY State .I Med
1974; 74: 1426-38.
Lindblom D, Bjork vo, Semb BKA. Mechanical failure of the Bjork-
Shiley valve. J Thorac Cardiovasc Surg 1986; 92: 894-907.
Locander W, Sudman S, Bradburn N. An investigation of interview
method, threat and response distortion. J Am Statist Assoc
1976; 7l: 269-75.
Loop FD, Carabajul N, Taylor P et al. Internal mammary artery bypass
graft in re-operative myocardial revascularization. Am J Cardiol
1976; 37: 890-5.
Loop FD, Cosgrove DM, Lytle BW et al.
coronary arterial surgery (1967-1978).
444-55.
An 11 year evolution of
Ann Surg 19791' 170:
Loop FD, sheldon w, Lytle BW et al. The efficacy of coronary artery
surgery. Am Heart J 1981; 101: 86-96.
Love JW. Employment status after coronary bypass operations and
some cost considerations. J Thorac cardiovasc surg 1980; 80:
68 -7 2.
188
Lyons AS. cardiac surgery. In: Medicine. An Illustrated History, by
Lyons As, Petrucelli RJ (1978). Harry N Abrams, Incorporated,
New York, pp 593-5.
Lytle Bw, cosgrove DM, Loop FD. Replacement of aortic valve
combined with myocardial revascularization determinants of
early and late risk for 500 patients 1967-1981. Círculatíon
1983;68: 1149-62.
Lytle Bw, Cosgrove DM, Gill CC et al. Mitral valve replacement
combined with myocardial revascularization: early and late
results for 300 patients 1970 to 1983. circulation 1985a; 7l:
tt79-90.
Lytle Bw, Loop FD, cosgrove DM et al. Long-term (5 to rz years)
serial studies of internal mammary artery and saphenous vein
coronary bypass grafts. J Thorac cardiovasc surg 1985b; 89:
248-58.
Lytle BV/, Loop FD, Cosgrove DM et al. Fifteen hundred coronary
reoperations: Results and determinants of early and late
survival. f Thorac Cardiovasc Surg 1987: 93: 847-59.
Lytle BW, Loop FD. coronary reoperations. surg ctin Nth Am 1988;
68: 559-80.
Mcclung JA, Stein JH, Ambrose JA et al. prosthetic heart valves: A
Review. Prog Cardíovasc Dis 1983; 26:237-70.
189
McCormick JR, McCabe CH, Kronmal RA et al. Operative mortality and
longterm survival in surgically treated patients with unstable
angina: CASS experience. J Am Coll Cardiol 1983; l: 632
(Abstract).
McHenry MM, Smeloff EA, Davey TB et al. Hemodynamic results with
full-flow orifice prosthetic valves. Circulation 1967; 35t36
(Suppl 1): 24-33.
MacManus Q, Grunkemeier GL, Lambert LE et al. Year of operation as
a risk factor in the late results of valve replacement. J Thorac
Cardiovasc Surg 1980; 80: 834-41.
Madow WG. Net differences in interview data on chronic conditions
compared with information derived from medical records. Vital
and Health statistics PHS 1973; publication no. 1000, series 2,
no. 57. Washington DC: GPO.
Magovern JA, Pennock JL, Campbell DB et al. Risks of mitral valve
replacement and mitral valve replacement with coronary artery
bypass. Ann Thorac Surg 1985; 39: 346-52.
Meier B, Gruentzig A. Learning curve for Percutaneous Transluminal
coronary Angioplasty: skill, Technology or patient selection. Am
J Cardiol 1984;53: 65-6.
Meltzer JW, Hochstim JR. Reliability and validity of survey dara on
physical health. Public Health Rep l97O; 85: 1075-86.
190
Miller DC, Stinson EB, Rossiter SJ et al. Impact of simultaneous
myocardial revascularization on operative risk, function result
and survival following mitral valve replacement. Surgery 1978;
84: 848-57.
Miller DC, Stinson EB, Oyer PE et al. Surgical implications and results
of combined aortic valve replacement and myocardial
revascularization. Am J Cardiol 1979; 43: 494-501.
Miller DC, Oyer PE, Stinson EB et al. Ten to fifteen year reassessment
of the performance characteristics of the Starr-Edwards Model
Gl20 mitral valve prosthesis. .I Thorac Cardiovasc Surg 1983a;
85: l-2O-
Miller DC, Stinson EB, Oyer PE et al. Discriminant analysis of the
changing risks of coronary artery operations: l97l-1979. J
Thorac Cardíovo,sc Surg 1983b; 85 (2): 197-213.
Moise A, Theroux P, Taeymans Y et al. Clinical and angiographic
factors associated with progression of coronary artery disease. I
Am Coll Cardiol 1984; 3 (3): 659-67.
Moore CH, Martelli V, Al-Janabin N et al. Analysis of homograft valve
failure in 311 patients followed up to l0 years. Ann Thorac
Surg 1975¡' 20: 274-81.
Mork T. Some problems related to the use of mail questionnaires. I
Chronic Dis 1970; 23: 399-4M.
191
Morris JB, Schirmer \VJ.
surgeons. Surgery
The "Right Stuff": Five Nobel Púze-winning
1990; 108: 71-80.
Murphy DA, Craver JM, Jones EH et al. Surgical revascularization
following unsuccessful percutaneous transluminal coronary
angioplasty. J Thorac Cardíovasc Surg 1982; 8a (3): 342-8.
Murphy DA, Levine FH, Buckley MJ et al. Mechanical valves: A
comparative analysis of the Starr Edwards and Bjork-Shiley
prothesis. J Thorac Cardíovasc Surg 1983; 86: 746-52.
Murray G. Homologous aortic-valve segment transplants as surgical
treatment for aortic and mitral insufficiency. Angiology 1956;
7: 466-71.
Najafi H. Update on surgical management of coronary artery disease
Arch Dermatot 1983; 119 (ll): 930-3.
Namay DL, Hammermeister KE, Zia MS et al. Effect of peri-operative
myocardial infarction on late survival in patients undergoing
coronary artery bypass surgery. Circulation 1982: 65: 1066-71.
Nicoloff DM, Emery RV/. Current Status of the St Jude Ca¡diac valve
prosthesis . Contemp Surg 1979; 15: I l.
Niles NW, Vander-Salm TJ, Cutler BS. Return to work af.ter coronary
artety bypass operation. J Thorac Cardíovasc Surg 1980; 79:
916-21.
r92
Norris RM, Agnew TM, Brandt PNT et al. Coronary surgery after
recurrent myocardial infarction: Progress of a trial comparing
surgical with nonsurgical management for asymptomatic
patients with advanced coronary disease. Círculation 1981; 63
(4): 785-92.
Norwood W, Cohn L, Collins J. Results of re-operation for recurrent
angina pectoris. Ann Thorac Surg 1977; 23: 9-13.
Nunley DL, Grukemeier GL, Starr A. Aortic Valve replacement with
coronary bypass grafting: significant determinants of ten year
survival. J Thorac Cardíovasc Surg 1983; 85: 705-11.
Oberman A, Kouchoukos NT.
coronary bypass surgery.
Working status of patients following
Am Heart J 1979; 98: 132-4.
Oberman A, Wayne JB, Kouchoukos NT et al. Employment status after
coronary artery bypass surgery. Circulation L982; 65 (7 Pt. 2
Suppl): 115-9.
Oglietti J, Cooley DA. Myocardial revascularization - Early and late
results after re-operation. J Thorac Cardiovasc Surg 1976; 7l:
736-40.
Ostermeyer J, Horstkotte D, Bennett J et al. The Bjork-Shiley 700
convex-concave prosthesis strut fracture problem (present state
of information). Thorac Cardiovasc Surg 1987;35:71-7.
r93
o'Toole BI, Battistutta D, Long A et al. A comparison of costs and data
quality of three health surveys. Methods: mail, telephone and
personal home interview. Am J Epidemiol 1986; 124 (2): 317-
28.
Palac RT, Meadows wR, Hwang MH et al. Risk factors related to
progressive narrowing in aortocoronary vein grafts studied one
and five years after surgery. círculation l9B2; 66 (suppl I): I
40-4.
Pluth JR. What is the status of coronary revascularization for acute
myocardial infarction? Cardiovasc Clín 1983; 13: 183-90.
Proudfit WL, Bruschke AVG, MacMillan JP et al. Fifteen year survival
study of patients with obstructive coronary artery disease.
Círculation 1983; 68 (5): 986-97.
Rahimtoola SH, Grunkemeir GL, Tepley JF et al. Changes in coronary
bypass surgery leading to improved survival. J AM A lgïl; 246
(t7): t9t2-6.
Rehn L. Zur experimentellen Pathologie des Herzbeutels. Ver Deutsch
Ges Chir l9l3; 2 Teil: 339-52.
Reul G, Cooley D, Ott D et al. Re-operation for recurrent coronary
artery disease. Arch Surg 1979; ll4: 1269-75.
Richardson JV, Kouchovkos NT, Wright JO et al. Combined aortic valve
replacement and myocardial revascularization results in 220
194
patients. Circulation 1979; 59: 75-81.
Roberts V/C, Bulkley BH, Morrow AG. Pathologic anatomy of cardiac
valve replacement. A study of 224 necropsy patients. P r o g
Cardíovasc Dis 1973:' 15: 539-87.
Roberts WC, Hammer WJ. Cardiac pathology after valve replacement
with a tilting disc prosthesis (Bjork-Shiley type): A study of 46
necropsy patients and 49 Bjork-Shiley prostheses. Am J Cardiol
1976; 37 (7): tO24-33.
Robicsek F, Sanger P'W, Daugherty HK et al. Fatal arrhythmias caused
by the pressure of the ball-valve prothesis upon the left
ventricular myocardium. Dis Chest 1967; 52: 813-6.
Roe BB, Fishman NH, Hutchinson JC, et al. Occluder disruption of
Wada-Cutter valve prosthesis. Ann Thorac Surg 1975; 2O (3):
25 6-64.
Rogers wJ, Smith LR, oberman A et al. Return of LV in full function
after reperfusion in patients with myocardial infarction:
importance of subtotal stensoses or intact collaterals. Circulatíon
1984; 69: 338-49.
Ross DN. Homograft replacement of the aortic valve. Lancet 1962; 2:
487.
Ross DN. Biologic valves: Their performance and prospects.
Círculation 1972; 45: 1259-72.
195
Russel Ro, wayne JB, Kronenfeld J et al. Surgical versus medical
therapy for treatment of unstable angina: Changes in work
status and family income. Am J Cardiol 1980; 45: 134-40.
Salomon NW, Page SU, Okies JE et al. Diabetes mellitus and coronary
artery bypass. J Thorac Cardiovasc Surg 1983; 85: 264-71.
Santinga JT, Kirsh MM. Haemolytic anemia in series 23oo and 2310
Starr-Edwards prosthetic valves. Ann Thorac Surg 1972; 14:
539-44.
Schaff HV, orzulak TA, Gersh BJ et al. The morbidity and mortality of
re-operation for coronary artery disease and analysis of late
results with use of actuarial estimate of event-free interval. I
Thorac Cardiovasc Surg 1983; 85: 508-15.
Scientific Information Retrieval (SIR) data base manager (First edition
1980, SIR, Inc.) Evanston, United States of America.
Seldinger SI. Catheter replacement of the needle in percutaneous
arteriography; a new technique. Acta Radiol 1953; 39: 368-76.
Shub C, Vlietstra RE, Smith HC et al. The unpredictable progression of
symptomatic coronary artery disease: a. serial clinical
angiographic analysis. Mayo Clin Proc 1981; 56: 155-60.
Siemiatycki JA. A comparison of mail, telephone, and home interview
strategies for household health surveys. Am J Publíc Health
1979; 69: 238-45. df.
196
silverman KJ, Grossman \ry. Angina pectoris: Natural history and
strageies for evaluation and management. N Eng J Med l9B4
3 10: l7 l2-7 .
Singh RW, Sosa JA,
mammary artery
Cardioyasc Surg
Greene GE. Longterm fate of




Slaughter L, Morris JF, Starr A.
year review. Circulation
Prosthetic valvular endocarditis. A 12
1973; 47: 1319-26.
Smith HC, Hammes LN, Gupta S
coronary artery bypass surgery.
et al. Employment status after
Circulation 1982; 65: 120-5.
Sones FM Jr, Shirey EK. cine coronary arteriography. Mod conc
Cardiovasc Dis 1962; 3l: 735-8.
Spodick DH. Indications for coronary bypass surgery,
Controlled trials scientifically and ethically optimum"
Cardiol 1982; 31: 45-50.
t982:
Adv
Stamler J. The prevention and control of epidemic coronary heart
disease: scientific foundations and strategic approaches. Int J
Cardiol 1983; 4: 2O7-15.
Starr A, Edwards ML. Mitral replacement: Clinical experience with a
ball-valve prothesis. Ann Surg 1961; 154: 726-40.
r97
Starr A, Herr RH, v/ood JA. Mitral Replacement: Review of six years
experience. J Thorac Cardiov Surg 1967;54: 333-58.
Starr A. Discussion of Isom et al: Long term evaluation of cloth-
covered metallic ball prostheses. J Thorac Cardíovasc Surg
1972:' 64: 354-67.
Starr A, Grunkemeier GL, Lambert L et al. Mitral valve replacement :
r ten-year follow-up of non cloth-covered vs. cloth-covered
caged-ball prostheses. Circulation 1976:- 54: III 47-56.
Starr A, Grunkemeier GL, Lambert L et al.
composite strut (track valve) protheses.
55156 (Suppl III): 29 (abstract).
Clinical results with
C irc ulation 1977a;
with non-
I Thorac
Starr A, Grunkemeier GL, Lambert L. Aortic valve replacement: a ten-
year follow-up of non-cloth-covered vs. cloth-covered caged ball
prostheses. Circulatíon 1977b; 56 : II 133-9.
Stein DW, Selden R, Starr A. Thrombotic phenomena
anticoagulated composite-strut aortic prostheses.
Cardiovasc Surg 1976;71: 680-4.
Symmes JC, Lenkei ScM, Berman ND. Influence of aortocoronary
bypass surgery on employment. Can Med Assoc J 1978; ll8:
268-7 0 .
Talley JD, Jones EL, weintraub ws et al. coronary Artery Bypass
Surgery After Failed Elective Percutaneous Transluminal
198
Coronary Angioplasty. Circulation 1989; 79 (Suppl l): 126-31.
Tector AJ, Schmahl TM, Janson B et al. The internal mammary artery
graft: Its longevity after coronary bypass. JAMA l98l; 246:
2r8t-3.
Thomas cS, Alford WC, Burrus GR et al. Results of re-operation for
failed aortocoronary bypass grafts. Arch surg 1976; I I l: lzlo-
3.
Thompson R, Ahmed M, seabra-Gomes R et al. Influence of pre-
operative left ventricular function on results of homograft
replacement of the aortic valve for aortic regurgitation. J Thorac
Cardiovasc Surg 1979; 77: 4ll-21.
Thulin LI, Bain wH, Huysmans HH et al. Heart valve replacement
with Bjork-Shiley Monostrut valve: early results of multicenter
clinical investigations. Ann Thorac Surg 1988; 45: 164-70.
Tschernenkov CI, Symes JF, Sniderman Do et al. Improvement in
resting ventricular performance following coronary artery
bypass surgery. Ann Thorac Surg 1985; 39: 340-5.
Tyson R, Grosh J, Reichler F. Re-do surgery for graft failure. Am J
Surg 1978; 136: 165-71.
vanderVeer JB, Rhyneer Gs, Hodam RP et al. obstruction of tricuspid
ball-valve prostheses. Circulation l97l1' a3 (l): 62-7.
199
Varnauskas E, Olsson SB, Ca¡lstrom E et al. prospective randomised
study of coronary artery bypass surgery in stable angina
pectoris. Lancet 1980; Z: 491-5.
wada J, Komatsu s, Kamata K. Cardiac valve replacement with the
Wada-Cutter prosrhesis. Stat Surg 1972; 14: 3g-46.
wallace RB. Tissue valves. Am J cardiol 1975;35 (6): 966-71.
Watanakunakorn C.
Cardiovasc Dis
Prosthetic valve infective endocarditis. p r o g
1979; 22: l8l-92.
Willman vL. Summary: Surgical Considerations. Am J Cardiol l9g4;
53 (t2): 116C.
winkle RA, Alderman EL, Shumway N. Results of re-operation for
unsuccessful coronary artery bypass surgery. Circulation 1975;
52 (l): 73-81.
wukasch D, Toscano M, cooley D et al. Re-operation following direct
myocardial revascularization. circulation 1977; 56 (3): ll3-7.
Zubiate P, Kay JH, Mendez AM. Myocardial revascularization for the
patient with drastic impairment of function of the left ventricle.
J Thorac Cardiovasc Surg 1977; 73: 84-6.
200
